{"paper_id": "2b6640afe74a0432a678523c69830cb4ca109e92", "metadata": {"title": "Supplementary Materials: Potential Drugs Targeting the SARS-Coronavirus 2 RNA Cap 2'-O- Methyltransferase nsp16/nsp10 Complex", "authors": [{"first": "Jos\u00e9", "middle": ["Antonio"], "last": "Encinar", "suffix": "", "affiliation": {}, "email": ""}, {"first": "Javier", "middle": ["A"], "last": "Menendez", "suffix": "", "affiliation": {}, "email": ""}]}, "abstract": [], "body_text": [{"text": "DB08237 is a purine 2'-deoxyribonucleoside monophosphate targeting the DNA polymerase kappa specifically involved in DNA repair. DB01897 is a phthalazinone targeting the hematopoietic prostaglandin D synthase, a bifunctional enzyme catalyzing both the conversion of PGH2 to PGD2 and the conjugation of glutathione with aryl halides and organic isothiocyanates. DB03571 is an n-benzylbenzamide dehydroneopterin targeting aldolase activity in S. aureus. Five of the predicted drugs were investigational ones, namely: DB11977 (golvatinib), DB12895 (TD-139), DB12899 (TT-301), DB13053 (CP-195543), and DB14870 (PF-5190457). Golvatinib (also known as E7050) is a diarylether that potently inhibits c-Met and VEGFR-2 tyrosine kinases that has been proposed as a lead compound for anti-hepatitis A drug development [1] [2] [3] . TD-139 is a disaccharide that has been investigated for the treatment of idiopathic pulmonary fibrosis [4-6]. TT-301 is a phenylpyridazine that has been used in trials studying the treatment of traumatic brain injury [7] . CP-195543 is a linear diarylhepatanoid that potent and selectively inhibits leukotriene B4 (LTB4) receptor and has been used in trials studying the treatment of arthritis rheumatoid [8, 9] . PF-5190457 is an orally bioavailable, potent, and selective GHS-R1a inverse agonist trialed to treat alcohol use disorder [10-12]. Two of the predicted compounds were FDA-approved drugs, namely: DB00320 (dihydroergotamine) and DB11986 (entrectinib). Dihydroergotamine is a 9,10 alpha-dihydro derivative of ergotamine that binds with high affinity to 5-HT1Da and 5-HT11Db receptors and has been used for the therapy of migraine disorders by non-oral routes including an approved nasal spray formulation [13] [14] [15] . Entrectinib is an FDA-approved phenylpiparezine that functions as a tropomyosin receptor tyrosine kinase (TRK) TRKA, TRKB, TRKC, proto-oncogene tyrosine-protein kinase ROS1, and anaplastic lymphoma kinase (ALK) inhibitor in the treatment of ROS1positive metastatic non-small-cell lung cancer and NTRK gene fusion-positive solid tumors [16-18]. ", "cite_spans": [{"start": 808, "end": 811, "text": "[1]", "ref_id": "BIBREF0"}, {"start": 812, "end": 815, "text": "[2]", "ref_id": null}, {"start": 816, "end": 819, "text": "[3]", "ref_id": null}, {"start": 1039, "end": 1042, "text": "[7]", "ref_id": null}, {"start": 1227, "end": 1230, "text": "[8,", "ref_id": null}, {"start": 1231, "end": 1233, "text": "9]", "ref_id": null}, {"start": 1738, "end": 1742, "text": "[13]", "ref_id": null}, {"start": 1743, "end": 1747, "text": "[14]", "ref_id": null}, {"start": 1748, "end": 1752, "text": "[15]", "ref_id": null}], "ref_spans": [], "section": ""}, {"text": "Sonidegib (also named Odomzo) is a biphenyl derivative that antagonizes smoothened (SMO) to block the hedgehog (Hh) pathway and has been approved by the FDA to ", "cite_spans": [], "ref_spans": [], "section": "15"}, {"text": "Glycogen phosphorylase, muscle form Experimental . Ridinilazole is a targeted-spectrum antimicrobial that shows potential in treatment of Clostridium difficile infection [57, 58] . Itacitinib is a pyridinecarboxylic acid derivative that functions as an oral, selective inhibitor of the Janus Kinase (JAK) family of protein tyrosine kinases (TYKs) with selectivity for JAK1 in the treatment of inflammatory and neoplastic diseases [59,60]. Fenoverine is an old antispasmodic phenothiazine that inhibits calcium channel currents in smooth muscle cells [61] . Acelarin/NUC-1031, also known as fosgemcitabine palabenamide, is a pre-activated nucleotide analog (gemcitabine monophosphate) that incorporates a protective phosphoramidate moiety [62,63]. Two of the predicted compounds were FDA-approved drugs, namely: DB12457 (rimegepant) and DB08827 (lomitapide). Rimegepant is an imidazopyridine that functions as an oral antagonist of the CGRP receptor and has been approved for the acute treatment of migraine headache [64,65]. Lomitapide is a fluorene that directly inhibits microsomal triglyceride transfer protein (MTP) that has been approved as an orphan drug to reduce LDL cholesterol, total cholesterol, apolipoprotein B, and non-high-density lipoprotein (non-HDL) cholesterol in patients with homozygous familial hypercholesterolemia (HoFH) [66, 67] . Phthalocyanine is a cyclic tetrapyrrole that contains a phthalocyanine skeleton, which consists of four isoindole-type units, with the connecting carbon atoms in the macrocycle replaced by nitrogen. Metal derivatives of phthalocyanine have been studied for their photodynamic biocidal capacity against enveloped viruses [79-82]. MK-3207 is a potent and orally active CGRP receptor antagonists that has been used in trials studying the treatment of migraine and migraine disorders [83-85]. Lifirafenib (BGB-283) selectively binds to and inhibits the activity of wild-type BRAF and certain BRAF mutant forms, and EGFR [86]. Lifitegrast is a tetrahydroisoquinoline derivative that binds to the integrin lymphocyte function-associated antigen-1 (LFA-1), a cell surface protein found on leukocytes and blocks the interaction of LFA-1 with its cognate ligand intercellular adhesion molecule-1 (ICAM-1). Lifitegrast is a FDA approved drug for the treatment of keratoconjunctivitis sicca (dry eye syndrome) [87-89].", "cite_spans": [{"start": 170, "end": 174, "text": "[57,", "ref_id": "BIBREF58"}, {"start": 175, "end": 178, "text": "58]", "ref_id": null}, {"start": 550, "end": 554, "text": "[61]", "ref_id": null}, {"start": 1345, "end": 1349, "text": "[66,", "ref_id": "BIBREF6"}, {"start": 1350, "end": 1353, "text": "67]", "ref_id": null}], "ref_spans": [], "section": "DB03067"}, {"text": "Viruses 2020, 12, x; doi:", "cite_spans": [], "ref_spans": [], "section": "DB03067"}, {"text": "www.mdpi.com/journal/viruses ", "cite_spans": [], "ref_spans": [], "section": "DB03067"}], "bib_entries": {"BIBREF0": {"ref_id": "b0", "title": "E7050: a dual c-Met and VEGFR-2 tyrosine kinase inhibitor promotes tumor regression and prolongs survival in mouse xenograft models", "authors": [{"first": "T", "middle": [], "last": "Nakagawa", "suffix": ""}, {"first": "O", "middle": [], "last": "Tohyama", "suffix": ""}, {"first": "A", "middle": [], "last": "Yamaguchi", "suffix": ""}, {"first": "T", "middle": [], "last": "Matsushima", "suffix": ""}, {"first": "K", "middle": [], "last": "Takahashi", "suffix": ""}, {"first": "S", "middle": [], "last": "Funasaka", "suffix": ""}, {"first": "S", "middle": [], "last": "Shirotori", "suffix": ""}, {"first": "M", "middle": [], "last": "Asada", "suffix": ""}, {"first": "H", "middle": [], "last": "Obaishi", "suffix": ""}], "year": 2010, "venue": "Cancer Sci", "volume": "101", "issn": "", "pages": "210--215", "other_ids": {}}, "BIBREF1": {"ref_id": "b1", "title": "A phase I, dose-escalation study of the multitargeted receptor tyrosine kinase inhibitor, golvatinib, in patients with advanced solid tumors", "authors": [{"first": "L", "middle": ["R"], "last": "Molife", "suffix": ""}, {"first": "E", "middle": ["J"], "last": "Dean", "suffix": ""}, {"first": "M", "middle": [], "last": "Blanco-Codesido", "suffix": ""}, {"first": "M", "middle": ["G"], "last": "Krebs", "suffix": ""}, {"first": "A", "middle": ["T"], "last": "Brunetto", "suffix": ""}, {"first": "A", "middle": ["P"], "last": "Greystoke", "suffix": ""}, {"first": "Daniele", "middle": ["G"], "last": "Lee", "suffix": ""}, {"first": "L", "middle": [], "last": "Kuznetsov", "suffix": ""}, {"first": "G", "middle": [], "last": "Myint", "suffix": ""}, {"first": "K", "middle": ["T"], "last": "Wood", "suffix": ""}, {"first": "K", "middle": [], "last": "De Las Heras", "suffix": ""}, {"first": "B", "middle": [], "last": "Ranson", "suffix": ""}, {"first": "M", "middle": ["R"], "last": "", "suffix": ""}], "year": 2014, "venue": "Clin Cancer Res", "volume": "20", "issn": "", "pages": "6284--94", "other_ids": {}}, "BIBREF2": {"ref_id": "b2", "title": "Structural basis for neutralization of hepatitis A virus informs a rational design of highly potent inhibitors", "authors": [{"first": "L", "middle": [], "last": "Cao", "suffix": ""}, {"first": "P", "middle": [], "last": "Liu", "suffix": ""}, {"first": "P", "middle": [], "last": "Yang", "suffix": ""}, {"first": "Q", "middle": [], "last": "Gao", "suffix": ""}, {"first": "H", "middle": [], "last": "Li", "suffix": ""}, {"first": "Y", "middle": [], "last": "Sun", "suffix": ""}, {"first": "L", "middle": [], "last": "Zhu", "suffix": ""}, {"first": "J", "middle": [], "last": "Lin", "suffix": ""}, {"first": "D", "middle": [], "last": "Su", "suffix": ""}, {"first": "Z", "middle": [], "last": "Rao", "suffix": ""}, {"first": "X", "middle": [], "last": "Wang", "suffix": ""}], "year": 2019, "venue": "PLoS Biol", "volume": "17", "issn": "", "pages": "", "other_ids": {}}, "BIBREF3": {"ref_id": "b3", "title": "Regulation of transforming growth factor-\u03b21-driven lung fibrosis by galectin", "authors": [{"first": "A", "middle": ["C"], "last": "Mackinnon", "suffix": ""}, {"first": "M", "middle": ["A"], "last": "Gibbons", "suffix": ""}, {"first": "S", "middle": ["L"], "last": "Farnworth", "suffix": ""}, {"first": "H", "middle": [], "last": "Leffler", "suffix": ""}, {"first": "U", "middle": ["J"], "last": "Nilsson", "suffix": ""}, {"first": "Delaine", "middle": ["T"], "last": "Simpson", "suffix": ""}, {"first": "A", "middle": ["J"], "last": "Forbes", "suffix": ""}, {"first": "S", "middle": ["J"], "last": "Hirani", "suffix": ""}, {"first": "N", "middle": [], "last": "Gauldie", "suffix": ""}, {"first": "J", "middle": [], "last": "Sethi", "suffix": ""}, {"first": "T", "middle": [], "last": "", "suffix": ""}], "year": null, "venue": "", "volume": "", "issn": "", "pages": "", "other_ids": {}}, "BIBREF5": {"ref_id": "b5", "title": "Galectin-3 deficiency prevents concanavalin A-induced hepatitis in mice", "authors": [{"first": "V", "middle": [], "last": "Volarevic", "suffix": ""}, {"first": "M", "middle": [], "last": "Milovanovic", "suffix": ""}, {"first": "B", "middle": [], "last": "Ljujic", "suffix": ""}, {"first": "N", "middle": [], "last": "Pejnovic", "suffix": ""}, {"first": "N", "middle": [], "last": "Arsenijevic", "suffix": ""}, {"first": "U", "middle": [], "last": "Nilsson", "suffix": ""}, {"first": "H", "middle": [], "last": "Leffler", "suffix": ""}, {"first": "M", "middle": ["L"], "last": "Lukic", "suffix": ""}], "year": 2012, "venue": "Hepatology", "volume": "55", "issn": "", "pages": "1954--64", "other_ids": {}}, "BIBREF6": {"ref_id": "b6", "title": "Galectin-3 deficiency protects pancreatic islet cells from cytokine-triggered apoptosis in vitro", "authors": [{"first": "T", "middle": [], "last": "Saksida", "suffix": ""}, {"first": "I", "middle": [], "last": "Nikolic", "suffix": ""}, {"first": "M", "middle": [], "last": "Vujicic", "suffix": ""}, {"first": "U", "middle": ["J"], "last": "Nilsson", "suffix": ""}, {"first": "H", "middle": [], "last": "Leffler", "suffix": ""}, {"first": "M", "middle": ["L"], "last": "Lukic", "suffix": ""}, {"first": "I", "middle": [], "last": "Stojanovic", "suffix": ""}, {"first": "S", "middle": [], "last": "Stosic-Grujicic", "suffix": ""}], "year": 2013, "venue": "J Cell Physiol", "volume": "228", "issn": "", "pages": "1568--76", "other_ids": {}}, "BIBREF7": {"ref_id": "b7", "title": "TT-301 inhibits microglial activation and improves outcome after central nervous system injury in adult mice", "authors": [{"first": "M", "middle": ["L"], "last": "James", "suffix": ""}, {"first": "H", "middle": [], "last": "Wang", "suffix": ""}, {"first": "V", "middle": [], "last": "Cantillana", "suffix": ""}, {"first": "B", "middle": [], "last": "Lei", "suffix": ""}, {"first": "D", "middle": ["N"], "last": "Kernagis", "suffix": ""}, {"first": "H", "middle": ["N"], "last": "Dawson", "suffix": ""}, {"first": "L", "middle": ["D"], "last": "Klaman", "suffix": ""}, {"first": "D", "middle": ["T"], "last": "Laskowitz", "suffix": ""}], "year": 2012, "venue": "Anesthesiology", "volume": "116", "issn": "", "pages": "1299--311", "other_ids": {}}, "BIBREF8": {"ref_id": "b8", "title": "The preclinical pharmacological profile of the potent and selective leukotriene B4 antagonist CP-195543", "authors": [{"first": "H", "middle": ["J"], "last": "Showell", "suffix": ""}, {"first": "M", "middle": ["J"], "last": "Conklyn", "suffix": ""}, {"first": "R", "middle": [], "last": "Alpert", "suffix": ""}, {"first": "G", "middle": ["P"], "last": "Hingorani", "suffix": ""}, {"first": "K", "middle": ["F"], "last": "Wright", "suffix": ""}, {"first": "M", "middle": ["A"], "last": "Smith", "suffix": ""}, {"first": "E", "middle": [], "last": "Stam", "suffix": ""}, {"first": "E", "middle": ["D"], "last": "Salter", "suffix": ""}, {"first": "D", "middle": ["N"], "last": "Scampoli", "suffix": ""}, {"first": "S", "middle": [], "last": "Meltzer", "suffix": ""}, {"first": "L", "middle": ["A"], "last": "Reiter", "suffix": ""}, {"first": "K", "middle": [], "last": "Koch", "suffix": ""}, {"first": "A", "middle": ["D"], "last": "Piscopio", "suffix": ""}, {"first": "S", "middle": ["R"], "last": "Cortina", "suffix": ""}, {"first": "A", "middle": [], "last": "Lopez-Anaya", "suffix": ""}, {"first": "E", "middle": ["R"], "last": "Pettipher", "suffix": ""}, {"first": "A", "middle": ["J"], "last": "Milici", "suffix": ""}, {"first": "R", "middle": ["J"], "last": "Griffiths", "suffix": ""}], "year": 1998, "venue": "J Pharmacol Exp Ther", "volume": "285", "issn": "", "pages": "946--54", "other_ids": {}}, "BIBREF9": {"ref_id": "b9", "title": "The synthesis of CP-195543, an LTB4 antagonist for the treatment of inflammatory diseases", "authors": [{"first": "S", "middle": [], "last": "Caron", "suffix": ""}], "year": 1999, "venue": "Curr Opin Drug Discov Devel", "volume": "2", "issn": "", "pages": "550--556", "other_ids": {}}, "BIBREF10": {"ref_id": "b10", "title": "Discovery of PF-5190457, a Potent, Selective, and Orally Bioavailable Ghrelin Receptor Inverse Agonist Clinical Candidate", "authors": [{"first": "S", "middle": ["K"], "last": "Bhattacharya", "suffix": ""}, {"first": "K", "middle": [], "last": "Andrews", "suffix": ""}, {"first": "R", "middle": [], "last": "Beveridge", "suffix": ""}, {"first": "Cameron", "middle": [], "last": "Ko", "suffix": ""}, {"first": "C", "middle": [], "last": "Chen", "suffix": ""}, {"first": "M", "middle": [], "last": "Dunn", "suffix": ""}, {"first": "D", "middle": [], "last": "Fernando", "suffix": ""}, {"first": "H", "middle": [], "last": "Gao", "suffix": ""}, {"first": "D", "middle": [], "last": "Hepworth", "suffix": ""}, {"first": "V", "middle": ["M"], "last": "Jackson", "suffix": ""}, {"first": "V", "middle": [], "last": "Khot", "suffix": ""}, {"first": "J", "middle": [], "last": "Kong", "suffix": ""}, {"first": "R", "middle": ["E"], "last": "Kosa", "suffix": ""}, {"first": "K", "middle": [], "last": "Lapham", "suffix": ""}, {"first": "P", "middle": ["M"], "last": "Loria", "suffix": ""}, {"first": "A", "middle": ["T"], "last": "Londregan", "suffix": ""}, {"first": "K", "middle": ["F"], "last": "Mcclure", "suffix": ""}, {"first": "S", "middle": ["T"], "last": "Orr", "suffix": ""}, {"first": "J", "middle": [], "last": "Patel", "suffix": ""}, {"first": "C", "middle": [], "last": "Rose", "suffix": ""}, {"first": "J", "middle": [], "last": "Saenz", "suffix": ""}, {"first": "I", "middle": ["A"], "last": "Stock", "suffix": ""}, {"first": "G", "middle": [], "last": "Storer", "suffix": ""}, {"first": "M", "middle": [], "last": "Vanvolkenburg", "suffix": ""}, {"first": "D", "middle": [], "last": "Vrieze", "suffix": ""}, {"first": "G", "middle": [], "last": "Wang", "suffix": ""}, {"first": "J", "middle": [], "last": "Xiao", "suffix": ""}, {"first": "Y", "middle": [], "last": "Zhang", "suffix": ""}], "year": 2014, "venue": "ACS Med Chem Lett", "volume": "5", "issn": "", "pages": "474--483", "other_ids": {}}, "BIBREF11": {"ref_id": "b11", "title": "The novel ghrelin receptor inverse agonist PF-5190457 administered with alcohol: preclinical safety experiments and a phase 1b human laboratory study", "authors": [{"first": "M", "middle": ["R"], "last": "Lee", "suffix": ""}, {"first": "J", "middle": ["D"], "last": "Tapocik", "suffix": ""}, {"first": "M", "middle": [], "last": "Ghareeb", "suffix": ""}, {"first": "M", "middle": ["L"], "last": "Schwandt", "suffix": ""}, {"first": "A", "middle": ["A"], "last": "Dias", "suffix": ""}, {"first": "A", "middle": ["N"], "last": "Le", "suffix": ""}, {"first": "E", "middle": [], "last": "Cobbina", "suffix": ""}, {"first": "L", "middle": ["A"], "last": "Farinelli", "suffix": ""}, {"first": "S", "middle": [], "last": "Bouhlal", "suffix": ""}, {"first": "M", "middle": [], "last": "Farokhnia", "suffix": ""}, {"first": "M", "middle": [], "last": "Heilig", "suffix": ""}, {"first": "F", "middle": [], "last": "Akhlaghi", "suffix": ""}, {"first": "L", "middle": [], "last": "Leggio", "suffix": ""}], "year": 2020, "venue": "Mol Psychiatry", "volume": "25", "issn": "", "pages": "461--475", "other_ids": {}}, "BIBREF12": {"ref_id": "b12", "title": "Endocrine effects of the novel ghrelin receptor inverse agonist PF-5190457: Results from a placebocontrolled human laboratory alcohol co-administration study in heavy drinkers", "authors": [{"first": "M", "middle": ["R"], "last": "Lee", "suffix": ""}, {"first": "M", "middle": [], "last": "Farokhnia", "suffix": ""}, {"first": "E", "middle": [], "last": "Cobbina", "suffix": ""}, {"first": "A", "middle": [], "last": "Saravanakumar", "suffix": ""}, {"first": "X", "middle": [], "last": "Li", "suffix": ""}, {"first": "J", "middle": ["T"], "last": "Battista", "suffix": ""}, {"first": "L", "middle": ["A"], "last": "Farinelli", "suffix": ""}, {"first": "F", "middle": [], "last": "Akhlaghi", "suffix": ""}, {"first": "L", "middle": [], "last": "Leggio", "suffix": ""}], "year": 2019, "venue": "Neuropharmacology", "volume": "", "issn": "", "pages": "", "other_ids": {}}, "BIBREF13": {"ref_id": "b13", "title": "Dihydroergotamine: a review of formulation approaches for the acute treatment of migraine", "authors": [{"first": "S", "middle": ["D"], "last": "Silberstein", "suffix": ""}, {"first": "S", "middle": ["H"], "last": "Kori", "suffix": ""}], "year": 2013, "venue": "CNS Drugs", "volume": "27", "issn": "", "pages": "385--94", "other_ids": {}}, "BIBREF14": {"ref_id": "b14", "title": "Dihydroergotamine (DHE) -Then and Now: A Narrative Review", "authors": [{"first": "S", "middle": ["D"], "last": "Silberstein", "suffix": ""}, {"first": "S", "middle": ["B"], "last": "Shrewsbury", "suffix": ""}, {"first": "J", "middle": [], "last": "Hoekman", "suffix": ""}], "year": 2020, "venue": "Headache", "volume": "60", "issn": "", "pages": "40--57", "other_ids": {}}, "BIBREF15": {"ref_id": "b15", "title": "A Phase 1, Randomized, Open-Label, Safety, Tolerability, and Comparative Bioavailability Study of Intranasal Dihydroergotamine Powder (STS101), Intramuscular Dihydroergotamine Mesylate, and Intranasal DHE Mesylate Spray in Healthy Adult Subjects", "authors": [{"first": "D", "middle": [], "last": "Albrecht", "suffix": ""}, {"first": "M", "middle": [], "last": "Iwashima", "suffix": ""}, {"first": "D", "middle": [], "last": "Dillon", "suffix": ""}, {"first": "S", "middle": [], "last": "Harris", "suffix": ""}, {"first": "J", "middle": [], "last": "Levy", "suffix": ""}], "year": 2020, "venue": "Headache", "volume": "60", "issn": "", "pages": "701--712", "other_ids": {}}, "BIBREF16": {"ref_id": "b16", "title": "Safety and Antitumor Activity of the Multitargeted Pan-TRK, ROS1, and ALK Inhibitor Entrectinib: Combined Results from Two Phase I Trials", "authors": [{"first": "A", "middle": [], "last": "Drilon", "suffix": ""}, {"first": "S", "middle": [], "last": "Siena", "suffix": ""}, {"first": "S", "middle": ["I"], "last": "Ou", "suffix": ""}, {"first": "M", "middle": [], "last": "Patel", "suffix": ""}, {"first": "M", "middle": ["J"], "last": "Ahn", "suffix": ""}, {"first": "J", "middle": [], "last": "Lee", "suffix": ""}, {"first": "T", "middle": ["M"], "last": "Bauer", "suffix": ""}, {"first": "A", "middle": ["F"], "last": "Farago", "suffix": ""}, {"first": "J", "middle": ["J"], "last": "Wheler", "suffix": ""}, {"first": "S", "middle": ["V"], "last": "Liu", "suffix": ""}, {"first": "R", "middle": [], "last": "Doebele", "suffix": ""}, {"first": "L", "middle": [], "last": "Giannetta", "suffix": ""}, {"first": "G", "middle": [], "last": "Cerea", "suffix": ""}, {"first": "G", "middle": [], "last": "Marrapese", "suffix": ""}, {"first": "M", "middle": [], "last": "Schirru", "suffix": ""}, {"first": "A", "middle": [], "last": "Amatu", "suffix": ""}, {"first": "K", "middle": [], "last": "Bencardino", "suffix": ""}, {"first": "L", "middle": [], "last": "Palmeri", "suffix": ""}, {"first": "A", "middle": [], "last": "Sartore-Bianchi", "suffix": ""}, {"first": "A", "middle": [], "last": "Vanzulli", "suffix": ""}, {"first": "S", "middle": [], "last": "Cresta", "suffix": ""}, {"first": "S", "middle": [], "last": "Damian", "suffix": ""}, {"first": "M", "middle": [], "last": "Duca", "suffix": ""}, {"first": "E", "middle": [], "last": "Ardini", "suffix": ""}, {"first": "G", "middle": [], "last": "Li", "suffix": ""}, {"first": "J", "middle": [], "last": "Christiansen", "suffix": ""}, {"first": "K", "middle": [], "last": "Kowalski", "suffix": ""}, {"first": "A", "middle": ["D"], "last": "Johnson", "suffix": ""}, {"first": "R", "middle": [], "last": "Patel", "suffix": ""}, {"first": "D", "middle": [], "last": "Luo", "suffix": ""}, {"first": "E", "middle": [], "last": "Chow-Maneval", "suffix": ""}, {"first": "Z", "middle": [], "last": "Hornby", "suffix": ""}, {"first": "P", "middle": ["S"], "last": "Multani", "suffix": ""}, {"first": "A", "middle": ["T"], "last": "Shaw", "suffix": ""}, {"first": "De", "middle": [], "last": "Braud", "suffix": ""}, {"first": "F", "middle": ["G"], "last": "", "suffix": ""}], "year": 2017, "venue": "", "volume": "7", "issn": "", "pages": "400--409", "other_ids": {}}, "BIBREF17": {"ref_id": "b17", "title": "Doebele RC; trial investigators. Entrectinib in ROS1 fusion-positive non-small-cell lung cancer", "authors": [{"first": "A", "middle": [], "last": "Drilon", "suffix": ""}, {"first": "S", "middle": [], "last": "Siena", "suffix": ""}, {"first": "R", "middle": [], "last": "Dziadziuszko", "suffix": ""}, {"first": "F", "middle": [], "last": "Barlesi", "suffix": ""}, {"first": "M", "middle": ["G"], "last": "Krebs", "suffix": ""}, {"first": "A", "middle": ["T"], "last": "Shaw", "suffix": ""}, {"first": "F", "middle": [], "last": "De Braud", "suffix": ""}, {"first": "C", "middle": [], "last": "Rolfo", "suffix": ""}, {"first": "M", "middle": ["J"], "last": "Ahn", "suffix": ""}, {"first": "J", "middle": [], "last": "Wolf", "suffix": ""}, {"first": "T", "middle": [], "last": "Seto", "suffix": ""}, {"first": "B", "middle": ["C"], "last": "Cho", "suffix": ""}, {"first": "M", "middle": ["R"], "last": "Patel", "suffix": ""}, {"first": "C", "middle": ["H"], "last": "Chiu", "suffix": ""}, {"first": "T", "middle": [], "last": "John", "suffix": ""}, {"first": "K", "middle": [], "last": "Goto", "suffix": ""}, {"first": "C", "middle": ["S"], "last": "Karapetis", "suffix": ""}, {"first": "H", "middle": ["T"], "last": "Arkenau", "suffix": ""}, {"first": "S", "middle": ["W"], "last": "Kim", "suffix": ""}, {"first": "Y", "middle": [], "last": "Ohe", "suffix": ""}, {"first": "Y", "middle": ["C"], "last": "Li", "suffix": ""}, {"first": "Y", "middle": ["K"], "last": "Chae", "suffix": ""}, {"first": "C", "middle": ["H"], "last": "Chung", "suffix": ""}, {"first": "G", "middle": ["A"], "last": "Otterson", "suffix": ""}, {"first": "H", "middle": [], "last": "Murakami", "suffix": ""}, {"first": "C", "middle": ["C"], "last": "Lin", "suffix": ""}, {"first": "Dsw", "middle": [], "last": "Tan", "suffix": ""}, {"first": "H", "middle": [], "last": "Prenen", "suffix": ""}, {"first": "T", "middle": [], "last": "Riehl", "suffix": ""}, {"first": "E", "middle": [], "last": "Chow-Maneval", "suffix": ""}, {"first": "B", "middle": [], "last": "Simmons", "suffix": ""}, {"first": "N", "middle": [], "last": "Cui", "suffix": ""}, {"first": "A", "middle": [], "last": "Johnson", "suffix": ""}, {"first": "S", "middle": [], "last": "Eng", "suffix": ""}, {"first": "T", "middle": ["R"], "last": "Wilson", "suffix": ""}], "year": 2020, "venue": "Lancet Oncol", "volume": "21", "issn": "", "pages": "261--270", "other_ids": {}}, "BIBREF18": {"ref_id": "b18", "title": "Demetri GD; trial investigators. Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours", "authors": [{"first": "R", "middle": ["C"], "last": "Doebele", "suffix": ""}, {"first": "A", "middle": [], "last": "Drilon", "suffix": ""}, {"first": "L", "middle": [], "last": "Paz-Ares", "suffix": ""}, {"first": "S", "middle": [], "last": "Siena", "suffix": ""}, {"first": "A", "middle": ["T"], "last": "Shaw", "suffix": ""}, {"first": "A", "middle": ["F"], "last": "Farago", "suffix": ""}, {"first": "C", "middle": ["M"], "last": "Blakely", "suffix": ""}, {"first": "T", "middle": [], "last": "Seto", "suffix": ""}, {"first": "B", "middle": ["C"], "last": "Cho", "suffix": ""}, {"first": "D", "middle": [], "last": "Tosi", "suffix": ""}, {"first": "B", "middle": [], "last": "Besse", "suffix": ""}, {"first": "S", "middle": ["P"], "last": "Chawla", "suffix": ""}, {"first": "L", "middle": [], "last": "Bazhenova", "suffix": ""}, {"first": "J", "middle": ["C"], "last": "Krauss", "suffix": ""}, {"first": "Y", "middle": ["K"], "last": "Chae", "suffix": ""}, {"first": "M", "middle": [], "last": "Barve", "suffix": ""}, {"first": "I", "middle": [], "last": "Garrido-Laguna", "suffix": ""}, {"first": "S", "middle": ["V"], "last": "Liu", "suffix": ""}, {"first": "P", "middle": [], "last": "Conkling", "suffix": ""}, {"first": "T", "middle": [], "last": "John", "suffix": ""}, {"first": "M", "middle": [], "last": "Fakih", "suffix": ""}, {"first": "D", "middle": [], "last": "Sigal", "suffix": ""}, {"first": "H", "middle": ["H"], "last": "Loong", "suffix": ""}, {"first": "G", "middle": ["L"], "last": "Buchschacher", "suffix": ""}, {"first": "P", "middle": [], "last": "Garrido", "suffix": ""}, {"first": "J", "middle": [], "last": "Nieva", "suffix": ""}, {"first": "C", "middle": [], "last": "Steuer", "suffix": ""}, {"first": "T", "middle": ["R"], "last": "Overbeck", "suffix": ""}, {"first": "D", "middle": ["W"], "last": "Bowles", "suffix": ""}, {"first": "E", "middle": [], "last": "Fox", "suffix": ""}, {"first": "T", "middle": [], "last": "Riehl", "suffix": ""}, {"first": "E", "middle": [], "last": "Chow-Maneval", "suffix": ""}, {"first": "B", "middle": [], "last": "Simmons", "suffix": ""}, {"first": "N", "middle": [], "last": "Cui", "suffix": ""}, {"first": "A", "middle": [], "last": "Johnson", "suffix": ""}, {"first": "S", "middle": [], "last": "Eng", "suffix": ""}, {"first": "T", "middle": ["R"], "last": "Wilson", "suffix": ""}], "year": 2020, "venue": "Lancet Oncol", "volume": "21", "issn": "", "pages": "271--282", "other_ids": {}}, "BIBREF19": {"ref_id": "b19", "title": "Targeting tuberculosis and malaria through inhibition of Enoyl reductase: compound activity and structural data", "authors": [{"first": "M", "middle": ["R"], "last": "Kuo", "suffix": ""}, {"first": "H", "middle": ["R"], "last": "Morbidoni", "suffix": ""}, {"first": "D", "middle": [], "last": "Alland", "suffix": ""}, {"first": "S", "middle": ["F"], "last": "Sneddon", "suffix": ""}, {"first": "B", "middle": ["B"], "last": "Gourlie", "suffix": ""}, {"first": "M", "middle": ["M"], "last": "Staveski", "suffix": ""}, {"first": "M", "middle": [], "last": "Leonard", "suffix": ""}, {"first": "J", "middle": ["S"], "last": "Gregory", "suffix": ""}, {"first": "A", "middle": ["D"], "last": "Janjigian", "suffix": ""}, {"first": "C", "middle": [], "last": "Yee", "suffix": ""}, {"first": "J", "middle": ["M"], "last": "Musser", "suffix": ""}, {"first": "B", "middle": [], "last": "Kreiswirth", "suffix": ""}, {"first": "H", "middle": [], "last": "Iwamoto", "suffix": ""}, {"first": "R", "middle": [], "last": "Perozzo", "suffix": ""}, {"first": "W", "middle": ["R"], "last": "Jacobs", "suffix": ""}, {"first": "J", "middle": ["C"], "last": "Sacchettini", "suffix": ""}, {"first": "D", "middle": ["A"], "last": "Fidock", "suffix": ""}], "year": 2003, "venue": "J Biol Chem", "volume": "278", "issn": "", "pages": "20851--20860", "other_ids": {}}, "BIBREF20": {"ref_id": "b20", "title": "Design, synthesis and evaluation of new GEQ derivatives as inhibitors of InhA enzyme and Mycobacterium tuberculosis growth", "authors": [{"first": "A", "middle": [], "last": "Chollet", "suffix": ""}, {"first": "G", "middle": [], "last": "Mori", "suffix": ""}, {"first": "C", "middle": [], "last": "Menendez", "suffix": ""}, {"first": "F", "middle": [], "last": "Rodriguez", "suffix": ""}, {"first": "I", "middle": [], "last": "Fabing", "suffix": ""}, {"first": "M", "middle": ["R"], "last": "Pasca", "suffix": ""}, {"first": "J", "middle": [], "last": "Madacki", "suffix": ""}, {"first": "J", "middle": [], "last": "Kordul\u00e1kov\u00e1", "suffix": ""}, {"first": "P", "middle": [], "last": "Constant", "suffix": ""}, {"first": "A", "middle": [], "last": "Qu\u00e9mard", "suffix": ""}, {"first": "V", "middle": [], "last": "Bernardes-G\u00e9nisson", "suffix": ""}, {"first": "C", "middle": [], "last": "Lherbet", "suffix": ""}, {"first": "M", "middle": [], "last": "Baltas", "suffix": ""}], "year": 2015, "venue": "Eur J Med Chem", "volume": "101", "issn": "", "pages": "218--253", "other_ids": {}}, "BIBREF21": {"ref_id": "b21", "title": "Anticancer activity of CX-3543: a direct inhibitor of rRNA biogenesis", "authors": [{"first": "D", "middle": [], "last": "Drygin", "suffix": ""}, {"first": "A", "middle": [], "last": "Siddiqui-Jain", "suffix": ""}, {"first": "O", "middle": [], "last": "&apos;brien", "suffix": ""}, {"first": "S", "middle": [], "last": "Schwaebe", "suffix": ""}, {"first": "M", "middle": [], "last": "Lin", "suffix": ""}, {"first": "A", "middle": [], "last": "Bliesath", "suffix": ""}, {"first": "J", "middle": [], "last": "Ho", "suffix": ""}, {"first": "C", "middle": ["B"], "last": "Proffitt", "suffix": ""}, {"first": "C", "middle": [], "last": "Trent", "suffix": ""}, {"first": "K", "middle": [], "last": "Whitten", "suffix": ""}, {"first": "J", "middle": ["P"], "last": "Lim", "suffix": ""}, {"first": "J", "middle": ["K"], "last": "", "suffix": ""}, {"first": "Von", "middle": [], "last": "Hoff", "suffix": ""}, {"first": "D", "middle": [], "last": "Anderes", "suffix": ""}, {"first": "K", "middle": [], "last": "Rice", "suffix": ""}, {"first": "W", "middle": ["G"], "last": "", "suffix": ""}], "year": 2009, "venue": "Cancer Res", "volume": "69", "issn": "", "pages": "7653--61", "other_ids": {}}, "BIBREF22": {"ref_id": "b22", "title": "CX-5461 is a DNA Gquadruplex stabilizer with selective lethality in BRCA1/2 deficient tumours", "authors": [{"first": "H", "middle": [], "last": "Xu", "suffix": ""}, {"first": "Di", "middle": [], "last": "Antonio", "suffix": ""}, {"first": "M", "middle": [], "last": "Mckinney", "suffix": ""}, {"first": "S", "middle": [], "last": "Mathew", "suffix": ""}, {"first": "V", "middle": [], "last": "Ho", "suffix": ""}, {"first": "B", "middle": [], "last": "", "suffix": ""}, {"first": "O&apos;", "middle": [], "last": "Neil", "suffix": ""}, {"first": "N", "middle": ["J"], "last": "Santos", "suffix": ""}, {"first": "N", "middle": ["D"], "last": "Silvester", "suffix": ""}, {"first": "J", "middle": [], "last": "Wei", "suffix": ""}, {"first": "V", "middle": [], "last": "Garcia", "suffix": ""}, {"first": "J", "middle": [], "last": "Kabeer", "suffix": ""}, {"first": "F", "middle": [], "last": "Lai", "suffix": ""}, {"first": "D", "middle": [], "last": "Soriano", "suffix": ""}, {"first": "P", "middle": [], "last": "Ban\u00e1th", "suffix": ""}, {"first": "J", "middle": [], "last": "Chiu", "suffix": ""}, {"first": "D", "middle": ["S"], "last": "Yap", "suffix": ""}, {"first": "D", "middle": [], "last": "Le", "suffix": ""}, {"first": "D", "middle": ["D"], "last": "Ye", "suffix": ""}, {"first": "F", "middle": ["B"], "last": "Zhang", "suffix": ""}, {"first": "A", "middle": [], "last": "Thu", "suffix": ""}, {"first": "K", "middle": [], "last": "Soong", "suffix": ""}, {"first": "J", "middle": [], "last": "Lin", "suffix": ""}, {"first": "S", "middle": ["C"], "last": "Tsai", "suffix": ""}, {"first": "A", "middle": ["H"], "last": "Osako", "suffix": ""}, {"first": "T", "middle": [], "last": "Algara", "suffix": ""}, {"first": "T", "middle": [], "last": "Saunders", "suffix": ""}, {"first": "D", "middle": ["N"], "last": "Wong", "suffix": ""}, {"first": "J", "middle": [], "last": "Xian", "suffix": ""}, {"first": "J", "middle": [], "last": "Bally", "suffix": ""}, {"first": "M", "middle": ["B"], "last": "Brenton", "suffix": ""}, {"first": "J", "middle": ["D"], "last": "Brown", "suffix": ""}, {"first": "G", "middle": ["W"], "last": "Shah", "suffix": ""}, {"first": "S", "middle": ["P"], "last": "Cescon", "suffix": ""}, {"first": "D", "middle": [], "last": "Mak", "suffix": ""}, {"first": "T", "middle": ["W"], "last": "Caldas", "suffix": ""}, {"first": "C", "middle": [], "last": "Stirling", "suffix": ""}, {"first": "P", "middle": ["C"], "last": "Hieter", "suffix": ""}, {"first": "P", "middle": [], "last": "Balasubramanian", "suffix": ""}, {"first": "S", "middle": [], "last": "Aparicio", "suffix": ""}, {"first": "S", "middle": [], "last": "", "suffix": ""}], "year": 2017, "venue": "Nat Commun", "volume": "8", "issn": "", "pages": "", "other_ids": {}}, "BIBREF23": {"ref_id": "b23", "title": "Targeting G-quadruplexes in gene promoters: a novel anticancer strategy?", "authors": [{"first": "S", "middle": [], "last": "Balasubramanian", "suffix": ""}, {"first": "L", "middle": ["H"], "last": "Hurley", "suffix": ""}, {"first": "S", "middle": [], "last": "Neidle", "suffix": ""}], "year": 2011, "venue": "Nat Rev Drug Discov", "volume": "10", "issn": "", "pages": "261--75", "other_ids": {}}, "BIBREF24": {"ref_id": "b24", "title": "Selective inhibition of RNA polymerase I transcription as a potential approach to treat African trypanosomiasis", "authors": [{"first": "L", "middle": ["E"], "last": "Kerry", "suffix": ""}, {"first": "E", "middle": ["E"], "last": "Pegg", "suffix": ""}, {"first": "D", "middle": ["P"], "last": "Cameron", "suffix": ""}, {"first": "J", "middle": [], "last": "Budzak", "suffix": ""}, {"first": "G", "middle": [], "last": "Poortinga", "suffix": ""}, {"first": "K", "middle": ["M"], "last": "Hannan", "suffix": ""}, {"first": "R", "middle": ["D"], "last": "Hannan", "suffix": ""}, {"first": "G", "middle": [], "last": "Rudenko", "suffix": ""}], "year": 2017, "venue": "PLoS Negl Trop Dis", "volume": "11", "issn": "", "pages": "", "other_ids": {}}, "BIBREF25": {"ref_id": "b25", "title": "G-Quadruplex DNA Motifs in the Malaria Parasite Plasmodium falciparum and Their Potential as Novel Antimalarial Drug Targets", "authors": [{"first": "L", "middle": ["M"], "last": "Harris", "suffix": ""}, {"first": "K", "middle": ["R"], "last": "Monsell", "suffix": ""}, {"first": "F", "middle": [], "last": "Noulin", "suffix": ""}, {"first": "M", "middle": ["T"], "last": "Famodimu", "suffix": ""}, {"first": "N", "middle": [], "last": "Smargiasso", "suffix": ""}, {"first": "C", "middle": [], "last": "Damblon", "suffix": ""}, {"first": "P", "middle": [], "last": "Horrocks", "suffix": ""}, {"first": "C", "middle": ["J"], "last": "Merrick", "suffix": ""}], "year": 2018, "venue": "Antimicrob Agents Chemother", "volume": "62", "issn": "", "pages": "1828--1845", "other_ids": {}}, "BIBREF26": {"ref_id": "b26", "title": "Overcoming multidrug resistance in cancer: an update on the clinical strategy of inhibiting p-glycoprotein", "authors": [{"first": "H", "middle": [], "last": "Thomas", "suffix": ""}, {"first": "H", "middle": ["M"], "last": "Coley", "suffix": ""}], "year": 2003, "venue": "Cancer Control", "volume": "10", "issn": "", "pages": "159--65", "other_ids": {}}, "BIBREF27": {"ref_id": "b27", "title": "New-generation efflux pump inhibitors", "authors": [{"first": "M", "middle": [], "last": "Werle", "suffix": ""}, {"first": "H", "middle": [], "last": "Takeuchi", "suffix": ""}, {"first": "A", "middle": [], "last": "Bernkop-Schn\u00fcrch", "suffix": ""}], "year": 2008, "venue": "Expert Rev Clin Pharmacol", "volume": "1", "issn": "", "pages": "429--469", "other_ids": {}}, "BIBREF28": {"ref_id": "b28", "title": "Natural alkaloids as P-gp inhibitors for multidrug resistance reversal in cancer", "authors": [{"first": "P", "middle": [], "last": "Joshi", "suffix": ""}, {"first": "R", "middle": ["A"], "last": "Vishwakarma", "suffix": ""}, {"first": "S", "middle": ["B"], "last": "Bharate", "suffix": ""}], "year": 2017, "venue": "Eur J Med Chem", "volume": "138", "issn": "", "pages": "273--292", "other_ids": {}}, "BIBREF29": {"ref_id": "b29", "title": "Effective tumor cell death by sigma-2 receptor ligand siramesine involves lysosomal leakage and oxidative stress", "authors": [{"first": "M", "middle": ["S"], "last": "Ostenfeld", "suffix": ""}, {"first": "N", "middle": [], "last": "Fehrenbacher", "suffix": ""}, {"first": "M", "middle": [], "last": "H\u00f8yer-Hansen", "suffix": ""}, {"first": "C", "middle": [], "last": "Thomsen", "suffix": ""}, {"first": "T", "middle": [], "last": "Farkas", "suffix": ""}, {"first": "M", "middle": [], "last": "J\u00e4\u00e4ttel\u00e4", "suffix": ""}], "year": 2005, "venue": "Cancer Res", "volume": "65", "issn": "", "pages": "8975--83", "other_ids": {}}, "BIBREF30": {"ref_id": "b30", "title": "Anti-cancer agent siramesine is a lysosomotropic detergent that induces cytoprotective autophagosome accumulation", "authors": [{"first": "M", "middle": ["S"], "last": "Ostenfeld", "suffix": ""}, {"first": "M", "middle": [], "last": "H\u00f8yer-Hansen", "suffix": ""}, {"first": "L", "middle": [], "last": "Bastholm", "suffix": ""}, {"first": "N", "middle": [], "last": "Fehrenbacher", "suffix": ""}, {"first": "O", "middle": ["D"], "last": "Olsen", "suffix": ""}, {"first": "L", "middle": [], "last": "Groth-Pedersen", "suffix": ""}, {"first": "P", "middle": [], "last": "Puustinen", "suffix": ""}, {"first": "T", "middle": [], "last": "Kirkegaard-S\u00f8rensen", "suffix": ""}, {"first": "J", "middle": [], "last": "Nylandsted", "suffix": ""}, {"first": "T", "middle": [], "last": "Farkas", "suffix": ""}, {"first": "M", "middle": [], "last": "J\u00e4\u00e4ttel\u00e4", "suffix": ""}], "year": 2008, "venue": "Autophagy", "volume": "4", "issn": "", "pages": "487--99", "other_ids": {}}, "BIBREF31": {"ref_id": "b31", "title": "Lysosomotropic drugs activate TFEB via lysosomal membrane fluidization and consequent inhibition of mTORC1 activity", "authors": [{"first": "B", "middle": [], "last": "Zhitomirsky", "suffix": ""}, {"first": "A", "middle": [], "last": "Yunaev", "suffix": ""}, {"first": "R", "middle": [], "last": "Kreiserman", "suffix": ""}, {"first": "A", "middle": [], "last": "Kaplan", "suffix": ""}, {"first": "M", "middle": [], "last": "Stark", "suffix": ""}, {"first": "Y", "middle": ["G"], "last": "Assaraf", "suffix": ""}], "year": 2018, "venue": "Cell Death Dis", "volume": "9", "issn": "", "pages": "", "other_ids": {}}, "BIBREF32": {"ref_id": "b32", "title": "Ferroptosis is induced following siramesine and lapatinib treatment of breast cancer cells", "authors": [{"first": "S", "middle": [], "last": "Ma", "suffix": ""}, {"first": "E", "middle": ["S"], "last": "Henson", "suffix": ""}, {"first": "Y", "middle": [], "last": "Chen", "suffix": ""}, {"first": "S", "middle": ["B"], "last": "Gibson", "suffix": ""}], "year": 2016, "venue": "Cell Death Dis", "volume": "7", "issn": "", "pages": "", "other_ids": {}}, "BIBREF33": {"ref_id": "b33", "title": "Lysosomal Destabilizing Drug Siramesine and the Dual Tyrosine Kinase Inhibitor Lapatinib Induce a Synergistic Ferroptosis through Reduced Heme Oxygenase-1 (HO-1) Levels", "authors": [{"first": "G", "middle": ["E"], "last": "Villalpando-Rodriguez", "suffix": ""}, {"first": "A", "middle": ["R"], "last": "Blankstein", "suffix": ""}, {"first": "C", "middle": [], "last": "Konzelman", "suffix": ""}, {"first": "S", "middle": ["B"], "last": "Gibson", "suffix": ""}], "year": 2019, "venue": "Oxid Med Cell Longev", "volume": "", "issn": "", "pages": "", "other_ids": {}}, "BIBREF34": {"ref_id": "b34", "title": "Development of prodrug 4-chloro-3-(5-methyl-3-{[4-(2-pyrrolidin-1-ylethoxy)phenyl]amino}-1,2,4-benzotriazin-7-yl)phenyl benzoate (TG100801): a topically administered therapeutic candidate in clinical trials for the treatment of age-related macular degeneration", "authors": [{"first": "M", "middle": ["S"], "last": "Palanki", "suffix": ""}, {"first": "H", "middle": [], "last": "Akiyama", "suffix": ""}, {"first": "P", "middle": [], "last": "Campochiaro", "suffix": ""}, {"first": "J", "middle": [], "last": "Cao", "suffix": ""}, {"first": "C", "middle": ["P"], "last": "Chow", "suffix": ""}, {"first": "L", "middle": [], "last": "Dellamary", "suffix": ""}, {"first": "J", "middle": [], "last": "Doukas", "suffix": ""}, {"first": "R", "middle": [], "last": "Fine", "suffix": ""}, {"first": "C", "middle": [], "last": "Gritzen", "suffix": ""}, {"first": "J", "middle": ["D"], "last": "Hood", "suffix": ""}, {"first": "S", "middle": [], "last": "Hu", "suffix": ""}, {"first": "S", "middle": [], "last": "Kachi", "suffix": ""}, {"first": "X", "middle": [], "last": "Kang", "suffix": ""}, {"first": "B", "middle": [], "last": "Klebansky", "suffix": ""}, {"first": "A", "middle": [], "last": "Kousba", "suffix": ""}, {"first": "D", "middle": [], "last": "Lohse", "suffix": ""}, {"first": "C", "middle": ["C"], "last": "Mak", "suffix": ""}, {"first": "M", "middle": [], "last": "Martin", "suffix": ""}, {"first": "A", "middle": [], "last": "Mcpherson", "suffix": ""}, {"first": "V", "middle": ["P"], "last": "Pathak", "suffix": ""}, {"first": "J", "middle": [], "last": "Renick", "suffix": ""}, {"first": "R", "middle": [], "last": "Soll", "suffix": ""}, {"first": "N", "middle": [], "last": "Umeda", "suffix": ""}, {"first": "S", "middle": [], "last": "Yee", "suffix": ""}, {"first": "K", "middle": [], "last": "Yokoi", "suffix": ""}, {"first": "B", "middle": [], "last": "Zeng", "suffix": ""}, {"first": "H", "middle": [], "last": "Zhu", "suffix": ""}, {"first": "G", "middle": [], "last": "Noronha", "suffix": ""}], "year": 2008, "venue": "J Med Chem", "volume": "51", "issn": "", "pages": "1546--59", "other_ids": {}}, "BIBREF35": {"ref_id": "b35", "title": "An anti-inflammatory role of VEGFR2/Src kinase inhibitor in herpes simplex virus 1-induced immunopathology", "authors": [{"first": "S", "middle": [], "last": "Sharma", "suffix": ""}, {"first": "S", "middle": [], "last": "Mulik", "suffix": ""}, {"first": "N", "middle": [], "last": "Kumar", "suffix": ""}, {"first": "A", "middle": [], "last": "Suryawanshi", "suffix": ""}, {"first": "B", "middle": ["T"], "last": "Rouse", "suffix": ""}], "year": 2011, "venue": "J Virol", "volume": "85", "issn": "", "pages": "5995--6007", "other_ids": {}}, "BIBREF36": {"ref_id": "b36", "title": "Systematic review and meta-analysis of the efficacy of tirilazad in experimental stroke", "authors": [{"first": "E", "middle": [], "last": "Sena", "suffix": ""}, {"first": "P", "middle": [], "last": "Wheble", "suffix": ""}, {"first": "P", "middle": [], "last": "Sandercock", "suffix": ""}, {"first": "M", "middle": [], "last": "Macleod", "suffix": ""}], "year": 2007, "venue": "Stroke", "volume": "38", "issn": "", "pages": "388--94", "other_ids": {}}, "BIBREF37": {"ref_id": "b37", "title": "Effects of lazaroids on intestinal ischemia and reperfusion injury in experimental models", "authors": [{"first": "I", "middle": ["I"], "last": "Flessas", "suffix": ""}, {"first": "A", "middle": ["E"], "last": "Papalois", "suffix": ""}, {"first": "K", "middle": [], "last": "Toutouzas", "suffix": ""}, {"first": "F", "middle": [], "last": "Zagouri", "suffix": ""}, {"first": "G", "middle": ["C"], "last": "Zografos", "suffix": ""}], "year": 2011, "venue": "J Surg Res", "volume": "166", "issn": "", "pages": "265--74", "other_ids": {}}, "BIBREF38": {"ref_id": "b38", "title": "Discovery of Vibegron: A Potent and Selective \u03b23 Adrenergic Receptor Agonist for the Treatment of Overactive Bladder", "authors": [{"first": "S", "middle": ["D"], "last": "Edmondson", "suffix": ""}, {"first": "C", "middle": [], "last": "Zhu", "suffix": ""}, {"first": "N", "middle": ["F"], "last": "Kar", "suffix": ""}, {"first": "Di", "middle": [], "last": "Salvo", "suffix": ""}, {"first": "J", "middle": [], "last": "Nagabukuro", "suffix": ""}, {"first": "H", "middle": [], "last": "Sacre-Salem", "suffix": ""}, {"first": "B", "middle": [], "last": "Dingley", "suffix": ""}, {"first": "K", "middle": [], "last": "Berger", "suffix": ""}, {"first": "R", "middle": [], "last": "Goble", "suffix": ""}, {"first": "S", "middle": ["D"], "last": "Morriello", "suffix": ""}, {"first": "G", "middle": [], "last": "Harper", "suffix": ""}, {"first": "B", "middle": [], "last": "Moyes", "suffix": ""}, {"first": "C", "middle": ["R"], "last": "Shen", "suffix": ""}, {"first": "D", "middle": ["M"], "last": "Wang", "suffix": ""}, {"first": "L", "middle": [], "last": "Ball", "suffix": ""}, {"first": "R", "middle": [], "last": "Fitzmaurice", "suffix": ""}, {"first": "A", "middle": [], "last": "Frenkl", "suffix": ""}, {"first": "T", "middle": [], "last": "Gichuru", "suffix": ""}, {"first": "L", "middle": ["N"], "last": "Ha", "suffix": ""}, {"first": "S", "middle": [], "last": "Hurley", "suffix": ""}, {"first": "A", "middle": ["L"], "last": "Jochnowitz", "suffix": ""}, {"first": "N", "middle": [], "last": "Levorse", "suffix": ""}, {"first": "D", "middle": [], "last": "Mistry", "suffix": ""}, {"first": "S", "middle": [], "last": "Miller", "suffix": ""}, {"first": "R", "middle": ["R"], "last": "Ormes", "suffix": ""}, {"first": "J", "middle": [], "last": "Salituro", "suffix": ""}, {"first": "G", "middle": ["M"], "last": "Sanfiz", "suffix": ""}, {"first": "A", "middle": [], "last": "Stevenson", "suffix": ""}, {"first": "A", "middle": ["S"], "last": "Villa", "suffix": ""}, {"first": "K", "middle": [], "last": "Zamlynny", "suffix": ""}, {"first": "B", "middle": [], "last": "Green", "suffix": ""}, {"first": "S", "middle": [], "last": "Struthers", "suffix": ""}, {"first": "M", "middle": [], "last": "Weber", "suffix": ""}, {"first": "A", "middle": ["E"], "last": "", "suffix": ""}], "year": 2016, "venue": "J Med Chem", "volume": "59", "issn": "", "pages": "609--632", "other_ids": {}}, "BIBREF39": {"ref_id": "b39", "title": "Efficacy of vibegron, a novel \u03b23-adrenoreceptor agonist, on severe urgency urinary incontinence related to overactive bladder: post hoc analysis of a randomized, placebo-controlled, doubleblind, comparative phase 3 study", "authors": [{"first": "M", "middle": [], "last": "Yoshida", "suffix": ""}, {"first": "M", "middle": [], "last": "Takeda", "suffix": ""}, {"first": "M", "middle": [], "last": "Gotoh", "suffix": ""}, {"first": "O", "middle": [], "last": "Yokoyama", "suffix": ""}, {"first": "H", "middle": [], "last": "Kakizaki", "suffix": ""}, {"first": "S", "middle": [], "last": "Takahashi", "suffix": ""}, {"first": "N", "middle": [], "last": "Masumori", "suffix": ""}, {"first": "S", "middle": [], "last": "Nagai", "suffix": ""}, {"first": "K", "middle": [], "last": "Minemura", "suffix": ""}], "year": 2020, "venue": "BJU Int", "volume": "", "issn": "", "pages": "", "other_ids": {"DOI": ["10.1111/bju.15020"]}}, "BIBREF40": {"ref_id": "b40", "title": "International Phase III, Randomized, Double-Blind, Placebo-and Active-Controlled Study to Evaluate the Safety and Efficacy of Vibegron in Patients with Symptoms of Overactive Bladder: EMPOWUR", "authors": [{"first": "D", "middle": [], "last": "Staskin", "suffix": ""}, {"first": "J", "middle": [], "last": "Frankel", "suffix": ""}, {"first": "S", "middle": [], "last": "Varano", "suffix": ""}, {"first": "D", "middle": [], "last": "Shortino", "suffix": ""}, {"first": "R", "middle": [], "last": "Jankowich", "suffix": ""}, {"first": "P", "middle": ["N"], "last": "Mudd", "suffix": ""}], "year": 2020, "venue": "J Urol", "volume": "", "issn": "", "pages": "101097--0000000000000807", "other_ids": {}}, "BIBREF41": {"ref_id": "b41", "title": "The HCV nonnucleoside inhibitor Tegobuvir utilizes a novel mechanism of action to inhibit NS5B polymerase function", "authors": [{"first": "C", "middle": ["M"], "last": "Hebner", "suffix": ""}, {"first": "B", "middle": [], "last": "Han", "suffix": ""}, {"first": "K", "middle": ["M"], "last": "Brendza", "suffix": ""}, {"first": "M", "middle": [], "last": "Nash", "suffix": ""}, {"first": "M", "middle": [], "last": "Sulfab", "suffix": ""}, {"first": "Y", "middle": [], "last": "Tian", "suffix": ""}, {"first": "M", "middle": [], "last": "Hung", "suffix": ""}, {"first": "W", "middle": [], "last": "Fung", "suffix": ""}, {"first": "R", "middle": ["W"], "last": "Vivian", "suffix": ""}, {"first": "J", "middle": [], "last": "Trenkle", "suffix": ""}, {"first": "J", "middle": [], "last": "Taylor", "suffix": ""}, {"first": "K", "middle": [], "last": "Bjornson", "suffix": ""}, {"first": "S", "middle": [], "last": "Bondy", "suffix": ""}, {"first": "X", "middle": [], "last": "Liu", "suffix": ""}, {"first": "J", "middle": [], "last": "Link", "suffix": ""}, {"first": "J", "middle": [], "last": "Neyts", "suffix": ""}, {"first": "R", "middle": [], "last": "Sakowicz", "suffix": ""}, {"first": "W", "middle": [], "last": "Zhong", "suffix": ""}, {"first": "H", "middle": [], "last": "Tang", "suffix": ""}, {"first": "U", "middle": [], "last": "Schmitz", "suffix": ""}], "year": 2012, "venue": "PLoS One", "volume": "7", "issn": "", "pages": "", "other_ids": {}}, "BIBREF42": {"ref_id": "b42", "title": "All-oral combination of ledipasvir, vedroprevir, tegobuvir, and ribavirin in treatment-na\u00efve patients with genotype 1 HCV infection", "authors": [{"first": "D", "middle": ["L"], "last": "Wyles", "suffix": ""}, {"first": "M", "middle": [], "last": "Rodriguez-Torres", "suffix": ""}, {"first": "E", "middle": [], "last": "Lawitz", "suffix": ""}, {"first": "M", "middle": ["L"], "last": "Shiffman", "suffix": ""}, {"first": "S", "middle": [], "last": "Pol", "suffix": ""}, {"first": "R", "middle": ["W"], "last": "Herring", "suffix": ""}, {"first": "B", "middle": [], "last": "Massetto", "suffix": ""}, {"first": "B", "middle": [], "last": "Kanwar", "suffix": ""}, {"first": "J", "middle": ["D"], "last": "Trenkle", "suffix": ""}, {"first": "P", "middle": ["S"], "last": "Pang", "suffix": ""}, {"first": "Y", "middle": [], "last": "Zhu", "suffix": ""}, {"first": "H", "middle": [], "last": "Mo", "suffix": ""}, {"first": "D", "middle": ["M"], "last": "Brainard", "suffix": ""}, {"first": "G", "middle": ["M"], "last": "Subramanian", "suffix": ""}, {"first": "J", "middle": ["G"], "last": "Mchutchison", "suffix": ""}, {"first": "F", "middle": [], "last": "Habersetzer", "suffix": ""}, {"first": "M", "middle": ["S"], "last": "Sulkowski", "suffix": ""}], "year": 2014, "venue": "Hepatology", "volume": "60", "issn": "", "pages": "56--64", "other_ids": {}}, "BIBREF43": {"ref_id": "b43", "title": "In vitro combinations containing Tegobuvir are highly efficient in curing cells from HCV replicon and in delaying/preventing the development of drug resistance", "authors": [{"first": "I", "middle": [], "last": "Vliegen", "suffix": ""}, {"first": "J", "middle": [], "last": "Paeshuyse", "suffix": ""}, {"first": "W", "middle": [], "last": "Zhong", "suffix": ""}, {"first": "J", "middle": [], "last": "Neyts", "suffix": ""}], "year": 2015, "venue": "Antiviral Res", "volume": "120", "issn": "", "pages": "112--133", "other_ids": {}}, "BIBREF44": {"ref_id": "b44", "title": "Design, synthesis, and structure-activity relationships of novel imidazo[4 ,5-c]pyridine derivatives as potent non-nucleoside inhibitors of hepatitis C virus NS5B", "authors": [{"first": "M", "middle": [], "last": "Liu", "suffix": ""}, {"first": "Q", "middle": [], "last": "Xu", "suffix": ""}, {"first": "S", "middle": [], "last": "Guo", "suffix": ""}, {"first": "R", "middle": [], "last": "Zuo", "suffix": ""}, {"first": "Y", "middle": [], "last": "Hong", "suffix": ""}, {"first": "Y", "middle": [], "last": "Luo", "suffix": ""}, {"first": "Y", "middle": [], "last": "Li", "suffix": ""}, {"first": "P", "middle": [], "last": "Gong", "suffix": ""}, {"first": "Y", "middle": [], "last": "Liu", "suffix": ""}], "year": 2018, "venue": "Bioorg Med Chem", "volume": "26", "issn": "", "pages": "2621--2631", "other_ids": {}}, "BIBREF45": {"ref_id": "b45", "title": "Major Depressive Disorder and Kappa Opioid Receptor Antagonists", "authors": [{"first": "W", "middle": [], "last": "Li", "suffix": ""}, {"first": "H", "middle": [], "last": "Sun", "suffix": ""}, {"first": "H", "middle": [], "last": "Chen", "suffix": ""}, {"first": "X", "middle": [], "last": "Yang", "suffix": ""}, {"first": "L", "middle": [], "last": "Xiao", "suffix": ""}, {"first": "R", "middle": [], "last": "Liu", "suffix": ""}, {"first": "L", "middle": [], "last": "Shao", "suffix": ""}, {"first": "Z", "middle": [], "last": "Qiu", "suffix": ""}], "year": 2016, "venue": "Transl Perioper Pain Med", "volume": "1", "issn": "", "pages": "4--16", "other_ids": {}}, "BIBREF46": {"ref_id": "b46", "title": "Behavioral Pharmacology of Novel Kappa Opioid Receptor Antagonists in Rats", "authors": [{"first": "S", "middle": [], "last": "Page", "suffix": ""}, {"first": "M", "middle": ["M"], "last": "Mavrikaki", "suffix": ""}, {"first": "T", "middle": [], "last": "Lintz", "suffix": ""}, {"first": "D", "middle": [], "last": "Puttick", "suffix": ""}, {"first": "E", "middle": [], "last": "Roberts", "suffix": ""}, {"first": "H", "middle": [], "last": "Rosen", "suffix": ""}, {"first": "F", "middle": ["I"], "last": "Carroll", "suffix": ""}, {"first": "W", "middle": ["A"], "last": "Carlezon", "suffix": ""}, {"first": "Eh ;", "middle": [], "last": "Chartoff", "suffix": ""}, {"first": "F", "middle": [], "last": "Ali", "suffix": ""}, {"first": "M", "middle": ["A"], "last": "Raufi", "suffix": ""}, {"first": "B", "middle": [], "last": "Washington", "suffix": ""}, {"first": "J", "middle": ["K"], "last": "Ghali", "suffix": ""}], "year": 2007, "venue": "Int J Neuropsychopharmacol", "volume": "22", "issn": "", "pages": "261--79", "other_ids": {}}, "BIBREF47": {"ref_id": "b47", "title": "Conivaptan: a dual vasopressin receptor v1a/v2 antagonist", "authors": [{"first": "F", "middle": [], "last": "Ali", "suffix": ""}, {"first": "M", "middle": ["A"], "last": "Raufi", "suffix": ""}, {"first": "B", "middle": [], "last": "Washington", "suffix": ""}, {"first": "J", "middle": ["K"], "last": "Ghali", "suffix": ""}], "year": null, "venue": "", "volume": "", "issn": "", "pages": "", "other_ids": {}}, "BIBREF49": {"ref_id": "b49", "title": "Conivaptan and its role in the treatment of hyponatremia", "authors": [{"first": "J", "middle": ["K"], "last": "Ghali", "suffix": ""}, {"first": "J", "middle": ["O"], "last": "Farah", "suffix": ""}, {"first": "S", "middle": [], "last": "Daifallah", "suffix": ""}, {"first": "H", "middle": ["A"], "last": "Zabalawi", "suffix": ""}, {"first": "H", "middle": ["D"], "last": "Zmily", "suffix": ""}], "year": 2009, "venue": "Drug Des Devel Ther", "volume": "3", "issn": "", "pages": "253--68", "other_ids": {}}, "BIBREF50": {"ref_id": "b50", "title": "Sonidegib: First Global Approval", "authors": [{"first": "C", "middle": ["B"], "last": "Burness", "suffix": ""}], "year": 2015, "venue": "Drugs", "volume": "75", "issn": "", "pages": "1559--66", "other_ids": {}}, "BIBREF51": {"ref_id": "b51", "title": "The safety and efficacy of sonidegib for the treatment of locally advanced basal cell carcinoma", "authors": [{"first": "N", "middle": ["J"], "last": "Collier", "suffix": ""}, {"first": "F", "middle": ["R"], "last": "Ali", "suffix": ""}, {"first": "J", "middle": ["T"], "last": "Lear", "suffix": ""}], "year": 2016, "venue": "Expert Rev Anticancer Ther", "volume": "16", "issn": "", "pages": "1011--1019", "other_ids": {}}, "BIBREF52": {"ref_id": "b52", "title": "Sonidegib: mechanism of action, pharmacology, and clinical utility for advanced basal cell carcinomas", "authors": [{"first": "S", "middle": [], "last": "Jain", "suffix": ""}, {"first": "R", "middle": [], "last": "Song", "suffix": ""}, {"first": "J", "middle": [], "last": "Xie", "suffix": ""}], "year": 2017, "venue": "Onco Targets Ther", "volume": "10", "issn": "", "pages": "1645--1653", "other_ids": {}}, "BIBREF53": {"ref_id": "b53", "title": "Structure-based design of an osteoclast-selective, nonpeptide src homology 2 inhibitor with in vivo antiresorptive activity", "authors": [{"first": "W", "middle": [], "last": "Shakespeare", "suffix": ""}, {"first": "M", "middle": [], "last": "Yang", "suffix": ""}, {"first": "R", "middle": [], "last": "Bohacek", "suffix": ""}, {"first": "F", "middle": [], "last": "Cerasoli", "suffix": ""}, {"first": "K", "middle": [], "last": "Stebbins", "suffix": ""}, {"first": "R", "middle": [], "last": "Sundaramoorthi", "suffix": ""}, {"first": "M", "middle": [], "last": "Azimioara", "suffix": ""}, {"first": "C", "middle": [], "last": "Vu", "suffix": ""}, {"first": "S", "middle": [], "last": "Pradeepan", "suffix": ""}, {"first": "", "middle": [], "last": "Metcalf C 3rd", "suffix": ""}, {"first": "C", "middle": [], "last": "Haraldson", "suffix": ""}, {"first": "T", "middle": [], "last": "Merry", "suffix": ""}, {"first": "D", "middle": [], "last": "Dalgarno", "suffix": ""}, {"first": "S", "middle": [], "last": "Narula", "suffix": ""}, {"first": "M", "middle": [], "last": "Hatada", "suffix": ""}, {"first": "X", "middle": [], "last": "Lu", "suffix": ""}, {"first": "M", "middle": ["R"], "last": "Van Schravendijk", "suffix": ""}, {"first": "Adams", "middle": ["S"], "last": "Violette", "suffix": ""}, {"first": "S", "middle": [], "last": "Smith", "suffix": ""}, {"first": "J", "middle": [], "last": "Guan", "suffix": ""}, {"first": "W", "middle": [], "last": "Bartlett", "suffix": ""}, {"first": "C", "middle": [], "last": "Herson", "suffix": ""}, {"first": "J", "middle": [], "last": "Iuliucci", "suffix": ""}, {"first": "J", "middle": [], "last": "Weigele", "suffix": ""}, {"first": "M", "middle": [], "last": "Sawyer", "suffix": ""}, {"first": "T", "middle": [], "last": "", "suffix": ""}], "year": 2000, "venue": "Proc Natl Acad Sci U S A", "volume": "97", "issn": "", "pages": "9373--9381", "other_ids": {}}, "BIBREF54": {"ref_id": "b54", "title": "Inhibition of protein kinase c-Src as a therapeutic approach for cancer and bone metastases", "authors": [{"first": "N", "middle": [], "last": "Rucci", "suffix": ""}, {"first": "M", "middle": [], "last": "Susa", "suffix": ""}, {"first": "A", "middle": [], "last": "Teti", "suffix": ""}], "year": 2008, "venue": "Anticancer Agents Med Chem", "volume": "8", "issn": "", "pages": "342--351", "other_ids": {}}, "BIBREF55": {"ref_id": "b55", "title": "PKI-179: an orally efficacious dual phosphatidylinositol-3-kinase (PI3K)/mammalian target of rapamycin (mTOR) inhibitor", "authors": [{"first": "A", "middle": ["M"], "last": "Venkatesan", "suffix": ""}, {"first": "Z", "middle": [], "last": "Chen", "suffix": ""}, {"first": "O", "middle": [], "last": "Santos", "suffix": ""}, {"first": "C", "middle": [], "last": "Dehnhardt", "suffix": ""}, {"first": "E", "middle": ["D"], "last": "Santos", "suffix": ""}, {"first": "S", "middle": [], "last": "Ayral-Kaloustian", "suffix": ""}, {"first": "R", "middle": [], "last": "Mallon", "suffix": ""}, {"first": "I", "middle": [], "last": "Hollander", "suffix": ""}, {"first": "L", "middle": [], "last": "Feldberg", "suffix": ""}, {"first": "J", "middle": [], "last": "Lucas", "suffix": ""}, {"first": "K", "middle": [], "last": "Yu", "suffix": ""}, {"first": "I", "middle": [], "last": "Chaudhary", "suffix": ""}, {"first": "T", "middle": ["S"], "last": "Mansour", "suffix": ""}], "year": 2010, "venue": "Bioorg Med Chem Lett", "volume": "20", "issn": "", "pages": "5869--73", "other_ids": {}}, "BIBREF56": {"ref_id": "b56", "title": "A structural insight into the inhibitory mechanism of an orally active PI3K/mTOR dual inhibitor, PKI-179 using computational approaches", "authors": [{"first": "Mohd", "middle": [], "last": "Rehan", "suffix": ""}], "year": 2015, "venue": "J Mol Graph Model", "volume": "62", "issn": "", "pages": "226--234", "other_ids": {}}, "BIBREF57": {"ref_id": "b57", "title": "A small-molecule inhibitor of enterocytic microsomal triglyceride transfer protein, SLx-4090: biochemical, pharmacodynamic, pharmacokinetic, and safety profile", "authors": [{"first": "E", "middle": [], "last": "Kim", "suffix": ""}, {"first": "S", "middle": [], "last": "Campbell", "suffix": ""}, {"first": "O", "middle": [], "last": "Schueller", "suffix": ""}, {"first": "E", "middle": [], "last": "Wong", "suffix": ""}, {"first": "B", "middle": [], "last": "Cole", "suffix": ""}, {"first": "J", "middle": [], "last": "Kuo", "suffix": ""}, {"first": "J", "middle": [], "last": "Ellis", "suffix": ""}, {"first": "J", "middle": [], "last": "Ferkany", "suffix": ""}, {"first": "P", "middle": [], "last": "Sweetnam", "suffix": ""}], "year": 2011, "venue": "J Pharmacol Exp Ther", "volume": "337", "issn": "", "pages": "775--85", "other_ids": {}}, "BIBREF58": {"ref_id": "b58", "title": "Ridinilazole for the treatment of Clostridioides difficile infection", "authors": [{"first": "T", "middle": ["J"], "last": "Carlson", "suffix": ""}, {"first": "B", "middle": ["T"], "last": "Endres", "suffix": ""}, {"first": "E", "middle": [], "last": "Bass\u00e8res", "suffix": ""}, {"first": "A", "middle": ["J"], "last": "Gonzales-Luna", "suffix": ""}, {"first": "K", "middle": ["W"], "last": "Garey", "suffix": ""}], "year": 2019, "venue": "Expert Opin Investig Drugs", "volume": "28", "issn": "", "pages": "303--310", "other_ids": {}}, "BIBREF59": {"ref_id": "b59", "title": "Ridinilazole: a novel antimicrobial for Clostridium difficile infection", "authors": [{"first": "J", "middle": ["C"], "last": "Cho", "suffix": ""}, {"first": "M", "middle": ["P"], "last": "Crotty", "suffix": ""}, {"first": "J", "middle": [], "last": "Pardo", "suffix": ""}], "year": 2019, "venue": "Ann Gastroenterol", "volume": "32", "issn": "", "pages": "134--140", "other_ids": {}}, "BIBREF60": {"ref_id": "b60", "title": "Janus kinase (JAK) inhibitors in the treatment of inflammatory and neoplastic diseases", "authors": [{"first": "R", "middle": [], "last": "Roskoski", "suffix": ""}], "year": 2016, "venue": "Pharmacol Res", "volume": "111", "issn": "", "pages": "784--803", "other_ids": {}}, "BIBREF61": {"ref_id": "b61", "title": "Evaluation of Clinical Cardiac Safety of Itacitinib, a JAK1 Inhibitor, in Healthy Participants", "authors": [{"first": "X", "middle": [], "last": "Gong", "suffix": ""}, {"first": "B", "middle": [], "last": "Darpo", "suffix": ""}, {"first": "H", "middle": [], "last": "Xue", "suffix": ""}, {"first": "N", "middle": [], "last": "Punwani", "suffix": ""}, {"first": "K", "middle": [], "last": "He", "suffix": ""}, {"first": "A", "middle": ["M"], "last": "Barbour", "suffix": ""}, {"first": "N", "middle": [], "last": "Epstein", "suffix": ""}, {"first": "R", "middle": [], "last": "Landman", "suffix": ""}, {"first": "X", "middle": [], "last": "Chen", "suffix": ""}, {"first": "S", "middle": [], "last": "Yeleswaram", "suffix": ""}], "year": 2019, "venue": "Clin Pharmacol Drug Dev", "volume": "", "issn": "", "pages": "", "other_ids": {"DOI": ["10.1002/cpdd.758"]}}, "BIBREF62": {"ref_id": "b62", "title": "Fenoverine: a novel synchronizer of smooth muscle motility by interference with cellular calcium flow", "authors": [{"first": "J", "middle": [], "last": "Gonella", "suffix": ""}, {"first": "C", "middle": [], "last": "Lalanne", "suffix": ""}, {"first": "J", "middle": [], "last": "Mironneau", "suffix": ""}], "year": 1987, "venue": "Curr Med Res Opin", "volume": "10", "issn": "", "pages": "427--462", "other_ids": {}}, "BIBREF63": {"ref_id": "b63", "title": "Application of ProTide technology to gemcitabine: a successful approach to overcome the key cancer resistance mechanisms leads to a new agent (NUC-1031) in clinical development", "authors": [{"first": "M", "middle": [], "last": "Slusarczyk", "suffix": ""}, {"first": "M", "middle": ["H"], "last": "Lopez", "suffix": ""}, {"first": "J", "middle": [], "last": "Balzarini", "suffix": ""}, {"first": "M", "middle": [], "last": "Mason", "suffix": ""}, {"first": "W", "middle": ["G"], "last": "Jiang", "suffix": ""}, {"first": "S", "middle": [], "last": "Blagden", "suffix": ""}, {"first": "E", "middle": [], "last": "Thompson", "suffix": ""}, {"first": "E", "middle": [], "last": "Ghazaly", "suffix": ""}, {"first": "C", "middle": [], "last": "Mcguigan", "suffix": ""}], "year": 2014, "venue": "J Med Chem", "volume": "57", "issn": "", "pages": "1531--1573", "other_ids": {}}, "BIBREF64": {"ref_id": "b64", "title": "Anti-tumour activity of a first-in-class agent NUC-1031 in patients with advanced cancer: results of a phase I study", "authors": [{"first": "S", "middle": ["P"], "last": "Blagden", "suffix": ""}, {"first": "I", "middle": [], "last": "Rizzuto", "suffix": ""}, {"first": "P", "middle": [], "last": "Suppiah", "suffix": ""}, {"first": "O&apos;", "middle": [], "last": "Shea", "suffix": ""}, {"first": "D", "middle": [], "last": "Patel", "suffix": ""}, {"first": "M", "middle": [], "last": "Spiers", "suffix": ""}, {"first": "L", "middle": [], "last": "Sukumaran", "suffix": ""}, {"first": "A", "middle": [], "last": "Bharwani", "suffix": ""}, {"first": "N", "middle": [], "last": "Rockall", "suffix": ""}, {"first": "A", "middle": [], "last": "Gabra", "suffix": ""}, {"first": "H", "middle": [], "last": "El-Bahrawy", "suffix": ""}, {"first": "M", "middle": [], "last": "Wasan", "suffix": ""}, {"first": "H", "middle": [], "last": "Leonard", "suffix": ""}, {"first": "R", "middle": [], "last": "Habib", "suffix": ""}, {"first": "N", "middle": [], "last": "Ghazaly", "suffix": ""}, {"first": "E", "middle": [], "last": "", "suffix": ""}], "year": 2018, "venue": "Br J Cancer", "volume": "119", "issn": "", "pages": "815--822", "other_ids": {}}, "BIBREF65": {"ref_id": "b65", "title": "Rimegepant, an Oral Calcitonin Gene-Related Peptide Receptor Antagonist, for Migraine", "authors": [{"first": "R", "middle": ["B"], "last": "Lipton", "suffix": ""}, {"first": "R", "middle": [], "last": "Croop", "suffix": ""}, {"first": "E", "middle": ["G"], "last": "Stock", "suffix": ""}, {"first": "D", "middle": ["A"], "last": "Stock", "suffix": ""}, {"first": "B", "middle": ["A"], "last": "Morris", "suffix": ""}, {"first": "M", "middle": [], "last": "Frost", "suffix": ""}, {"first": "G", "middle": ["M"], "last": "Dubowchik", "suffix": ""}, {"first": "C", "middle": ["M"], "last": "Conway", "suffix": ""}, {"first": "V", "middle": [], "last": "Coric", "suffix": ""}, {"first": "P", "middle": ["J"], "last": "Goadsby", "suffix": ""}], "year": 2019, "venue": "N Engl J Med", "volume": "381", "issn": "", "pages": "142--149", "other_ids": {}}, "BIBREF66": {"ref_id": "b66", "title": "Efficacy, safety, and tolerability of rimegepant orally disintegrating tablet for the acute treatment of migraine: a randomised, phase 3, double-blind, placebo-controlled trial", "authors": [{"first": "R", "middle": [], "last": "Croop", "suffix": ""}, {"first": "P", "middle": ["J"], "last": "Goadsby", "suffix": ""}, {"first": "D", "middle": ["A"], "last": "Stock", "suffix": ""}, {"first": "C", "middle": ["M"], "last": "Conway", "suffix": ""}, {"first": "M", "middle": [], "last": "Forshaw", "suffix": ""}, {"first": "E", "middle": ["G"], "last": "Stock", "suffix": ""}, {"first": "V", "middle": [], "last": "Coric", "suffix": ""}, {"first": "R", "middle": ["B"], "last": "Lipton", "suffix": ""}], "year": 2019, "venue": "Lancet", "volume": "394", "issn": "", "pages": "737--745", "other_ids": {}}, "BIBREF67": {"ref_id": "b67", "title": "Inhibition of microsomal triglyceride transfer protein in familial hypercholesterolemia", "authors": [{"first": "M", "middle": [], "last": "Cuchel", "suffix": ""}, {"first": "L", "middle": ["T"], "last": "Bloedon", "suffix": ""}, {"first": "P", "middle": ["O"], "last": "Szapary", "suffix": ""}, {"first": "D", "middle": ["M"], "last": "Kolansky", "suffix": ""}, {"first": "M", "middle": ["L"], "last": "Wolfe", "suffix": ""}, {"first": "A", "middle": [], "last": "Sarkis", "suffix": ""}, {"first": "J", "middle": ["S"], "last": "Millar", "suffix": ""}, {"first": "K", "middle": [], "last": "Ikewaki", "suffix": ""}, {"first": "E", "middle": ["S"], "last": "Siegelman", "suffix": ""}, {"first": "R", "middle": ["E"], "last": "Gregg", "suffix": ""}, {"first": "D", "middle": ["J"], "last": "Rader", "suffix": ""}], "year": 2007, "venue": "N Engl J Med", "volume": "356", "issn": "", "pages": "148--56", "other_ids": {}}, "BIBREF69": {"ref_id": "b69", "title": "Efficacy and safety of a microsomal triglyceride transfer protein inhibitor in patients with homozygous familial hypercholesterolaemia: a single-arm, open-label, phase 3 study", "authors": [], "year": 2013, "venue": "Lancet", "volume": "381", "issn": "", "pages": "40--46", "other_ids": {}}, "BIBREF70": {"ref_id": "b70", "title": "R428, a selective small molecule inhibitor of Axl kinase, blocks tumor spread and prolongs survival in models of metastatic breast cancer", "authors": [{"first": "S", "middle": ["J"], "last": "Holland", "suffix": ""}, {"first": "A", "middle": [], "last": "Pan", "suffix": ""}, {"first": "C", "middle": [], "last": "Franci", "suffix": ""}, {"first": "Y", "middle": [], "last": "Hu", "suffix": ""}, {"first": "B", "middle": [], "last": "Chang", "suffix": ""}, {"first": "W", "middle": [], "last": "Li", "suffix": ""}, {"first": "M", "middle": [], "last": "Duan", "suffix": ""}, {"first": "A", "middle": [], "last": "Torneros", "suffix": ""}, {"first": "J", "middle": [], "last": "Yu", "suffix": ""}, {"first": "T", "middle": ["J"], "last": "Heckrodt", "suffix": ""}, {"first": "J", "middle": [], "last": "Zhang", "suffix": ""}, {"first": "P", "middle": [], "last": "Ding", "suffix": ""}, {"first": "A", "middle": [], "last": "Apatira", "suffix": ""}, {"first": "J", "middle": [], "last": "Chua", "suffix": ""}, {"first": "R", "middle": [], "last": "Brandt", "suffix": ""}, {"first": "P", "middle": [], "last": "Pine", "suffix": ""}, {"first": "D", "middle": [], "last": "Goff", "suffix": ""}, {"first": "R", "middle": [], "last": "Singh", "suffix": ""}, {"first": "D", "middle": ["G"], "last": "Payan", "suffix": ""}, {"first": "Y", "middle": [], "last": "Hitoshi", "suffix": ""}], "year": 2010, "venue": "Cancer Res", "volume": "70", "issn": "", "pages": "1544--54", "other_ids": {}}, "BIBREF71": {"ref_id": "b71", "title": "Activation of the Receptor Tyrosine Kinase AXL Regulates the Immune Microenvironment in Glioblastoma", "authors": [{"first": "H", "middle": [], "last": "Sadahiro", "suffix": ""}, {"first": "K", "middle": ["D"], "last": "Kang", "suffix": ""}, {"first": "J", "middle": ["T"], "last": "Gibson", "suffix": ""}, {"first": "M", "middle": [], "last": "Minata", "suffix": ""}, {"first": "H", "middle": [], "last": "Yu", "suffix": ""}, {"first": "J", "middle": [], "last": "Shi", "suffix": ""}, {"first": "R", "middle": [], "last": "Chhipa", "suffix": ""}, {"first": "Z", "middle": [], "last": "Chen", "suffix": ""}, {"first": "S", "middle": [], "last": "Lu", "suffix": ""}, {"first": "Y", "middle": [], "last": "Simoni", "suffix": ""}, {"first": "T", "middle": [], "last": "Furuta", "suffix": ""}, {"first": "H", "middle": [], "last": "Sabit", "suffix": ""}, {"first": "S", "middle": [], "last": "Zhang", "suffix": ""}, {"first": "S", "middle": [], "last": "Bastola", "suffix": ""}, {"first": "S", "middle": [], "last": "Yamaguchi", "suffix": ""}, {"first": "H", "middle": [], "last": "Alsheikh", "suffix": ""}, {"first": "S", "middle": [], "last": "Komarova", "suffix": ""}, {"first": "J", "middle": [], "last": "Wang", "suffix": ""}, {"first": "S", "middle": ["H"], "last": "Kim", "suffix": ""}, {"first": "D", "middle": [], "last": "Hambardzumyan", "suffix": ""}, {"first": "X", "middle": [], "last": "Lu", "suffix": ""}, {"first": "E", "middle": ["W"], "last": "Newell", "suffix": ""}, {"first": "B", "middle": [], "last": "Dasgupta", "suffix": ""}, {"first": "M", "middle": [], "last": "Nakada", "suffix": ""}, {"first": "L", "middle": ["J"], "last": "Lee", "suffix": ""}, {"first": "B", "middle": [], "last": "Nabors", "suffix": ""}, {"first": "L", "middle": ["A"], "last": "Norian", "suffix": ""}, {"first": "I", "middle": [], "last": "Nakano", "suffix": ""}], "year": 2018, "venue": "Cancer Res", "volume": "78", "issn": "", "pages": "3002--3013", "other_ids": {}}, "BIBREF72": {"ref_id": "b72", "title": "Small-Molecule Inhibition of Axl Targets Tumor Immune Suppression and Enhances Chemotherapy in Pancreatic Cancer", "authors": [{"first": "K", "middle": ["F"], "last": "Ludwig", "suffix": ""}, {"first": "W", "middle": [], "last": "Du", "suffix": ""}, {"first": "N", "middle": ["B"], "last": "Sorrelle", "suffix": ""}, {"first": "K", "middle": [], "last": "Wnuk-Lipinska", "suffix": ""}, {"first": "M", "middle": [], "last": "Topalovski", "suffix": ""}, {"first": "J", "middle": ["E"], "last": "Toombs", "suffix": ""}, {"first": "V", "middle": ["H"], "last": "Cruz", "suffix": ""}, {"first": "S", "middle": [], "last": "Yabuuchi", "suffix": ""}, {"first": "N", "middle": ["V"], "last": "Rajeshkumar", "suffix": ""}, {"first": "A", "middle": [], "last": "Maitra", "suffix": ""}, {"first": "J", "middle": ["B"], "last": "Lorens", "suffix": ""}, {"first": "R", "middle": ["A"], "last": "Brekken", "suffix": ""}], "year": 2018, "venue": "Cancer Res", "volume": "78", "issn": "", "pages": "246--255", "other_ids": {}}, "BIBREF73": {"ref_id": "b73", "title": "AXL targeting reduces fibrosis development in experimental unilateral ureteral obstruction", "authors": [{"first": "L", "middle": [], "last": "Landolt", "suffix": ""}, {"first": "J", "middle": [], "last": "Furriol", "suffix": ""}, {"first": "J", "middle": [], "last": "Babickova", "suffix": ""}, {"first": "L", "middle": [], "last": "Ahmed", "suffix": ""}, {"first": "\u00d8", "middle": [], "last": "Eikrem", "suffix": ""}, {"first": "T", "middle": [], "last": "Skogstrand", "suffix": ""}, {"first": "A", "middle": [], "last": "Scherer", "suffix": ""}, {"first": "S", "middle": [], "last": "Suliman", "suffix": ""}, {"first": "S", "middle": [], "last": "Leh", "suffix": ""}, {"first": "J", "middle": ["B"], "last": "Lorens", "suffix": ""}, {"first": "G", "middle": [], "last": "Gausdal", "suffix": ""}, {"first": "H", "middle": ["P"], "last": "Marti", "suffix": ""}, {"first": "T", "middle": [], "last": "Osman", "suffix": ""}], "year": 2019, "venue": "Physiol Rep", "volume": "7", "issn": "", "pages": "", "other_ids": {}}, "BIBREF74": {"ref_id": "b74", "title": "A Functional Role of GAS6/TAM in Nonalcoholic Steatohepatitis Progression Implicates AXL as Therapeutic Target", "authors": [{"first": "A", "middle": [], "last": "Tutusaus", "suffix": ""}, {"first": "E", "middle": [], "last": "De Gregorio", "suffix": ""}, {"first": "B", "middle": [], "last": "Cucarull", "suffix": ""}, {"first": "H", "middle": [], "last": "Crist\u00f3bal", "suffix": ""}, {"first": "C", "middle": [], "last": "Arest\u00e9", "suffix": ""}, {"first": "I", "middle": [], "last": "Graupera", "suffix": ""}, {"first": "M", "middle": [], "last": "Coll", "suffix": ""}, {"first": "A", "middle": [], "last": "Colell", "suffix": ""}, {"first": "G", "middle": [], "last": "Gausdal", "suffix": ""}, {"first": "J", "middle": ["B"], "last": "Lorens", "suffix": ""}, {"first": "Garc\u00eda", "middle": [], "last": "De Frutos", "suffix": ""}, {"first": "P", "middle": [], "last": "Morales", "suffix": ""}, {"first": "A", "middle": [], "last": "Mar\u00ed", "suffix": ""}, {"first": "M", "middle": [], "last": "", "suffix": ""}], "year": 2020, "venue": "Cell Mol Gastroenterol Hepatol", "volume": "9", "issn": "", "pages": "349--368", "other_ids": {}}, "BIBREF75": {"ref_id": "b75", "title": "CEP-32496: a novel orally active BRAF(V600E) inhibitor with selective cellular and in vivo antitumor activity", "authors": [{"first": "J", "middle": [], "last": "James", "suffix": ""}, {"first": "B", "middle": [], "last": "Ruggeri", "suffix": ""}, {"first": "R", "middle": ["C"], "last": "Armstrong", "suffix": ""}, {"first": "M", "middle": ["W"], "last": "Rowbottom", "suffix": ""}, {"first": "S", "middle": [], "last": "Jones-Bolin", "suffix": ""}, {"first": "R", "middle": ["N"], "last": "Gunawardane", "suffix": ""}, {"first": "P", "middle": [], "last": "Dobrzanski", "suffix": ""}, {"first": "M", "middle": ["F"], "last": "Gardner", "suffix": ""}, {"first": "H", "middle": [], "last": "Zhao", "suffix": ""}, {"first": "M", "middle": ["D"], "last": "Cramer", "suffix": ""}, {"first": "K", "middle": [], "last": "Hunter", "suffix": ""}, {"first": "R", "middle": ["R"], "last": "Nepomuceno", "suffix": ""}, {"first": "M", "middle": [], "last": "Cheng", "suffix": ""}, {"first": "D", "middle": [], "last": "Gitnick", "suffix": ""}, {"first": "M", "middle": [], "last": "Yazdanian", "suffix": ""}, {"first": "D", "middle": ["E"], "last": "Insko", "suffix": ""}, {"first": "M", "middle": ["A"], "last": "Ator", "suffix": ""}, {"first": "J", "middle": ["L"], "last": "Apuy", "suffix": ""}, {"first": "R", "middle": [], "last": "Faraoni", "suffix": ""}, {"first": "B", "middle": ["D"], "last": "Dorsey", "suffix": ""}, {"first": "M", "middle": [], "last": "Williams", "suffix": ""}, {"first": "S", "middle": ["S"], "last": "Bhagwat", "suffix": ""}, {"first": "M", "middle": ["W"], "last": "Holladay", "suffix": ""}], "year": 2012, "venue": "Mol Cancer Ther", "volume": "11", "issn": "", "pages": "930--971", "other_ids": {}}, "BIBREF76": {"ref_id": "b76", "title": "Antrafenine, naproxen and placebo in osteoarthritis: a comparative study", "authors": [{"first": "H", "middle": [], "last": "Berry", "suffix": ""}, {"first": "J", "middle": ["P"], "last": "Coquelin", "suffix": ""}, {"first": "A", "middle": [], "last": "Gordon", "suffix": ""}, {"first": "D", "middle": [], "last": "Seymour", "suffix": ""}], "year": 1983, "venue": "Br J Rheumatol", "volume": "22", "issn": "", "pages": "89--94", "other_ids": {}}, "BIBREF77": {"ref_id": "b77", "title": "Discovery of PF-04457845: A Highly Potent, Orally Bioavailable, and Selective Urea FAAH Inhibitor", "authors": [{"first": "D", "middle": ["S"], "last": "Johnson", "suffix": ""}, {"first": "C", "middle": [], "last": "Stiff", "suffix": ""}, {"first": "S", "middle": ["E"], "last": "Lazerwith", "suffix": ""}, {"first": "S", "middle": ["R"], "last": "Kesten", "suffix": ""}, {"first": "L", "middle": ["K"], "last": "Fay", "suffix": ""}, {"first": "M", "middle": [], "last": "Morris", "suffix": ""}, {"first": "D", "middle": [], "last": "Beidler", "suffix": ""}, {"first": "M", "middle": ["B"], "last": "Liimatta", "suffix": ""}, {"first": "S", "middle": ["E"], "last": "Smith", "suffix": ""}, {"first": "D", "middle": ["T"], "last": "Dudley", "suffix": ""}, {"first": "N", "middle": [], "last": "Sadagopan", "suffix": ""}, {"first": "S", "middle": ["N"], "last": "Bhattachar", "suffix": ""}, {"first": "S", "middle": ["J"], "last": "Kesten", "suffix": ""}, {"first": "T", "middle": ["K"], "last": "Nomanbhoy", "suffix": ""}, {"first": "B", "middle": ["F"], "last": "Cravatt", "suffix": ""}, {"first": "K", "middle": [], "last": "Ahn", "suffix": ""}], "year": 2011, "venue": "ACS Med Chem Lett", "volume": "2", "issn": "", "pages": "91--96", "other_ids": {}}, "BIBREF78": {"ref_id": "b78", "title": "Mechanistic and pharmacological characterization of PF-04457845: a highly potent and selective fatty acid amide hydrolase inhibitor that reduces inflammatory and noninflammatory pain", "authors": [{"first": "K", "middle": [], "last": "Ahn", "suffix": ""}, {"first": "S", "middle": ["E"], "last": "Smith", "suffix": ""}, {"first": "M", "middle": ["B"], "last": "Liimatta", "suffix": ""}, {"first": "D", "middle": [], "last": "Beidler", "suffix": ""}, {"first": "N", "middle": [], "last": "Sadagopan", "suffix": ""}, {"first": "D", "middle": ["T"], "last": "Dudley", "suffix": ""}, {"first": "T", "middle": [], "last": "Young", "suffix": ""}, {"first": "P", "middle": [], "last": "Wren", "suffix": ""}, {"first": "Y", "middle": [], "last": "Zhang", "suffix": ""}, {"first": "S", "middle": [], "last": "Swaney", "suffix": ""}, {"first": "K", "middle": [], "last": "Van Becelaere", "suffix": ""}, {"first": "J", "middle": ["L"], "last": "Blankman", "suffix": ""}, {"first": "D", "middle": ["K"], "last": "Nomura", "suffix": ""}, {"first": "S", "middle": ["N"], "last": "Bhattachar", "suffix": ""}, {"first": "C", "middle": [], "last": "Stiff", "suffix": ""}, {"first": "T", "middle": ["K"], "last": "Nomanbhoy", "suffix": ""}, {"first": "E", "middle": [], "last": "Weerapana", "suffix": ""}, {"first": "D", "middle": ["S"], "last": "Johnson", "suffix": ""}, {"first": "B", "middle": ["F"], "last": "Cravatt", "suffix": ""}], "year": 2011, "venue": "J Pharmacol Exp Ther", "volume": "338", "issn": "", "pages": "114--138", "other_ids": {}}, "BIBREF79": {"ref_id": "b79", "title": "Efficacy and safety of a fatty acid amide hydrolase inhibitor (PF-04457845) in the treatment of cannabis withdrawal and dependence in men: a double-blind, placebo-controlled, parallel group, phase 2a single-site randomised controlled trial", "authors": [{"first": "D", "middle": ["C"], "last": "D&apos;souza", "suffix": ""}, {"first": "J", "middle": [], "last": "Cortes-Briones", "suffix": ""}, {"first": "G", "middle": [], "last": "Creatura", "suffix": ""}, {"first": "G", "middle": [], "last": "Bluez", "suffix": ""}, {"first": "H", "middle": [], "last": "Thurnauer", "suffix": ""}, {"first": "E", "middle": [], "last": "Deaso", "suffix": ""}, {"first": "K", "middle": [], "last": "Bielen", "suffix": ""}, {"first": "T", "middle": [], "last": "Surti", "suffix": ""}, {"first": "R", "middle": [], "last": "Radhakrishnan", "suffix": ""}, {"first": "A", "middle": [], "last": "Gupta", "suffix": ""}, {"first": "S", "middle": [], "last": "Gupta", "suffix": ""}, {"first": "J", "middle": [], "last": "Cahill", "suffix": ""}, {"first": "M", "middle": ["A"], "last": "Sherif", "suffix": ""}, {"first": "A", "middle": [], "last": "Makriyannis", "suffix": ""}, {"first": "P", "middle": ["T"], "last": "Morgan", "suffix": ""}, {"first": "M", "middle": [], "last": "Ranganathan", "suffix": ""}, {"first": "P", "middle": ["D"], "last": "Skosnik", "suffix": ""}], "year": 2019, "venue": "Lancet Psychiatry", "volume": "6", "issn": "", "pages": "35--45", "other_ids": {}}, "BIBREF80": {"ref_id": "b80", "title": "A first-in-human phase I study of SAR125844, a selective MET tyrosine kinase inhibitor, in patients with advanced solid tumours with MET amplification", "authors": [{"first": "E", "middle": [], "last": "Angevin", "suffix": ""}, {"first": "G", "middle": [], "last": "Spitaleri", "suffix": ""}, {"first": "J", "middle": [], "last": "Rodon", "suffix": ""}, {"first": "K", "middle": [], "last": "Dotti", "suffix": ""}, {"first": "N", "middle": [], "last": "Isambert", "suffix": ""}, {"first": "S", "middle": [], "last": "Salvagni", "suffix": ""}, {"first": "V", "middle": [], "last": "Moreno", "suffix": ""}, {"first": "S", "middle": [], "last": "Assadourian", "suffix": ""}, {"first": "C", "middle": [], "last": "Gomez", "suffix": ""}, {"first": "M", "middle": [], "last": "Harnois", "suffix": ""}, {"first": "A", "middle": [], "last": "Hollebecque", "suffix": ""}, {"first": "A", "middle": [], "last": "Azaro", "suffix": ""}, {"first": "A", "middle": [], "last": "Hervieu", "suffix": ""}, {"first": "K", "middle": [], "last": "Rihawi", "suffix": ""}, {"first": "De", "middle": [], "last": "Marinis", "suffix": ""}, {"first": "F", "middle": [], "last": "", "suffix": ""}], "year": 2017, "venue": "Eur J Cancer", "volume": "87", "issn": "", "pages": "131--139", "other_ids": {}}, "BIBREF81": {"ref_id": "b81", "title": "Antifungal photodynamic therapy", "authors": [{"first": "R", "middle": ["F"], "last": "Donnelly", "suffix": ""}, {"first": "P", "middle": ["A"], "last": "Mccarron", "suffix": ""}, {"first": "M", "middle": ["M"], "last": "Tunney", "suffix": ""}], "year": 2008, "venue": "Microbiol Res", "volume": "163", "issn": "", "pages": "1--12", "other_ids": {}}, "BIBREF82": {"ref_id": "b82", "title": "Photodynamic Effect of some Phthalocyanines on Enveloped and Naked Viruses", "authors": [{"first": "L", "middle": [], "last": "Nikolaeva-Glomb", "suffix": ""}, {"first": "L", "middle": [], "last": "Mukova", "suffix": ""}, {"first": "N", "middle": [], "last": "Nikolova", "suffix": ""}, {"first": "V", "middle": [], "last": "Kussovski", "suffix": ""}, {"first": "L", "middle": [], "last": "Doumanova", "suffix": ""}, {"first": "V", "middle": [], "last": "Mantareva", "suffix": ""}, {"first": "I", "middle": [], "last": "Angelov", "suffix": ""}, {"first": "D", "middle": [], "last": "W\u00f6hrle", "suffix": ""}, {"first": "A", "middle": ["S"], "last": "Galabov", "suffix": ""}], "year": 2017, "venue": "Acta Virol", "volume": "61", "issn": "", "pages": "341--346", "other_ids": {}}, "BIBREF83": {"ref_id": "b83", "title": "Virus inactivation under the photodynamic effect of phthalocyanine zinc(II) complexes", "authors": [{"first": "M", "middle": [], "last": "Remichkova", "suffix": ""}, {"first": "L", "middle": [], "last": "Mukova", "suffix": ""}, {"first": "L", "middle": [], "last": "Nikolaeva-Glomb", "suffix": ""}, {"first": "N", "middle": [], "last": "Nikolova", "suffix": ""}, {"first": "L", "middle": [], "last": "Doumanova", "suffix": ""}, {"first": "V", "middle": [], "last": "Mantareva", "suffix": ""}, {"first": "I", "middle": [], "last": "Angelov", "suffix": ""}, {"first": "V", "middle": [], "last": "Kussovski", "suffix": ""}, {"first": "A", "middle": ["S"], "last": "Galabov", "suffix": ""}], "year": 2017, "venue": "Z Naturforsch C J Biosci", "volume": "72", "issn": "", "pages": "123--128", "other_ids": {}}, "BIBREF84": {"ref_id": "b84", "title": "Ultrastructural Aspects of Photodynamic Inactivation of Highly Pathogenic Avian H5N8 Influenza Virus", "authors": [{"first": "D", "middle": [], "last": "Korneev", "suffix": ""}, {"first": "O", "middle": [], "last": "Kurskaya", "suffix": ""}, {"first": "K", "middle": [], "last": "Sharshov", "suffix": ""}, {"first": "J", "middle": [], "last": "Eastwood", "suffix": ""}, {"first": "M", "middle": [], "last": "Strakhovskaya", "suffix": ""}], "year": 2019, "venue": "Viruses", "volume": "11", "issn": "", "pages": "", "other_ids": {}}, "BIBREF85": {"ref_id": "b85", "title": "Discovery of MK-3207: A Highly Potent", "authors": [{"first": "I", "middle": ["M"], "last": "Bell", "suffix": ""}, {"first": "S", "middle": ["N"], "last": "Gallicchio", "suffix": ""}, {"first": "M", "middle": ["R"], "last": "Wood", "suffix": ""}, {"first": "A", "middle": ["G"], "last": "Quigley", "suffix": ""}, {"first": "C", "middle": ["A"], "last": "Stump", "suffix": ""}, {"first": "C", "middle": ["B"], "last": "Zartman", "suffix": ""}, {"first": "J", "middle": ["F"], "last": "Fay", "suffix": ""}, {"first": "C", "middle": ["C"], "last": "Li", "suffix": ""}, {"first": "J", "middle": ["J"], "last": "Lynch", "suffix": ""}, {"first": "E", "middle": ["L"], "last": "Moore", "suffix": ""}, {"first": "S", "middle": ["D"], "last": "Mosser", "suffix": ""}, {"first": "T", "middle": [], "last": "Prueksaritanont", "suffix": ""}, {"first": "C", "middle": ["P"], "last": "Regan", "suffix": ""}, {"first": "S", "middle": [], "last": "Roller", "suffix": ""}, {"first": "C", "middle": ["A"], "last": "Salvatore", "suffix": ""}, {"first": "S", "middle": ["A"], "last": "Kane", "suffix": ""}, {"first": "J", "middle": ["P"], "last": "Vacca", "suffix": ""}, {"first": "H", "middle": ["G"], "last": "Selnick", "suffix": ""}], "year": 2010, "venue": "Orally Bioavailable CGRP Receptor Antagonist", "volume": "1", "issn": "", "pages": "24--33", "other_ids": {}}, "BIBREF86": {"ref_id": "b86", "title": "Randomized controlled trial of the CGRP receptor antagonist MK-3207 in the acute treatment of migraine", "authors": [{"first": "D", "middle": ["J"], "last": "Hewitt", "suffix": ""}, {"first": "S", "middle": ["K"], "last": "Aurora", "suffix": ""}, {"first": "D", "middle": ["W"], "last": "Dodick", "suffix": ""}, {"first": "P", "middle": ["J"], "last": "Goadsby", "suffix": ""}, {"first": "Y", "middle": ["J"], "last": "Ge", "suffix": ""}, {"first": "R", "middle": [], "last": "Bachman", "suffix": ""}, {"first": "D", "middle": [], "last": "Taraborelli", "suffix": ""}, {"first": "X", "middle": [], "last": "Fan", "suffix": ""}, {"first": "C", "middle": [], "last": "Assaid", "suffix": ""}, {"first": "C", "middle": [], "last": "Lines", "suffix": ""}, {"first": "T", "middle": ["W"], "last": "Ho", "suffix": ""}], "year": 2011, "venue": "Cephalalgia", "volume": "31", "issn": "", "pages": "712--734", "other_ids": {}}, "BIBREF87": {"ref_id": "b87", "title": "Novel oxazolidinone calcitonin gene-related peptide (CGRP) receptor antagonists for the acute treatment of migraine", "authors": [{"first": "B", "middle": ["M"], "last": "Crowley", "suffix": ""}, {"first": "C", "middle": ["A"], "last": "Stump", "suffix": ""}, {"first": "D", "middle": ["N"], "last": "Nguyen", "suffix": ""}, {"first": "C", "middle": ["M"], "last": "Potteiger", "suffix": ""}, {"first": "M", "middle": ["A"], "last": "Mcwherter", "suffix": ""}, {"first": "D", "middle": ["V"], "last": "Paone", "suffix": ""}, {"first": "A", "middle": ["G"], "last": "Quigley", "suffix": ""}, {"first": "J", "middle": ["G"], "last": "Bruno", "suffix": ""}, {"first": "D", "middle": [], "last": "Cui", "suffix": ""}, {"first": "J", "middle": ["C"], "last": "Culberson", "suffix": ""}, {"first": "A", "middle": [], "last": "Danziger", "suffix": ""}, {"first": "C", "middle": [], "last": "Fandozzi", "suffix": ""}, {"first": "D", "middle": [], "last": "Gauvreau", "suffix": ""}, {"first": "A", "middle": ["L"], "last": "Kemmerer", "suffix": ""}, {"first": "K", "middle": [], "last": "Menzel", "suffix": ""}, {"first": "E", "middle": ["L"], "last": "Moore", "suffix": ""}, {"first": "S", "middle": ["D"], "last": "Mosser", "suffix": ""}, {"first": "V", "middle": [], "last": "Reddy", "suffix": ""}, {"first": "R", "middle": ["B"], "last": "White", "suffix": ""}, {"first": "C", "middle": ["A"], "last": "Salvatore", "suffix": ""}, {"first": "S", "middle": ["A"], "last": "Kane", "suffix": ""}, {"first": "I", "middle": ["M"], "last": "Bell", "suffix": ""}, {"first": "H", "middle": ["G"], "last": "Selnick", "suffix": ""}, {"first": "M", "middle": ["E"], "last": "Fraley", "suffix": ""}, {"first": "C", "middle": ["S"], "last": "Burgey", "suffix": ""}], "year": 2015, "venue": "Bioorg Med Chem Lett", "volume": "25", "issn": "", "pages": "4777--4781", "other_ids": {}}, "BIBREF88": {"ref_id": "b88", "title": "Phase I, Open-Label, Dose-Escalation/Dose-Expansion Study of Lifirafenib (BGB-283), an RAF Family Kinase Inhibitor, in Patients With Solid Tumors", "authors": [{"first": "J", "middle": [], "last": "Desai", "suffix": ""}, {"first": "H", "middle": [], "last": "Gan", "suffix": ""}, {"first": "C", "middle": [], "last": "Barrow", "suffix": ""}, {"first": "M", "middle": [], "last": "Jameson", "suffix": ""}, {"first": "V", "middle": [], "last": "Atkinson", "suffix": ""}, {"first": "A", "middle": [], "last": "Haydon", "suffix": ""}, {"first": "M", "middle": [], "last": "Millward", "suffix": ""}, {"first": "S", "middle": [], "last": "Begbie", "suffix": ""}, {"first": "M", "middle": [], "last": "Brown", "suffix": ""}, {"first": "B", "middle": [], "last": "Markman", "suffix": ""}, {"first": "W", "middle": [], "last": "Patterson", "suffix": ""}, {"first": "A", "middle": [], "last": "Hill", "suffix": ""}, {"first": "L", "middle": [], "last": "Horvath", "suffix": ""}, {"first": "A", "middle": [], "last": "Nagrial", "suffix": ""}, {"first": "G", "middle": [], "last": "Richardson", "suffix": ""}, {"first": "C", "middle": [], "last": "Jackson", "suffix": ""}, {"first": "M", "middle": [], "last": "Friedlander", "suffix": ""}, {"first": "P", "middle": [], "last": "Parente", "suffix": ""}, {"first": "B", "middle": [], "last": "Tran", "suffix": ""}, {"first": "L", "middle": [], "last": "Wang", "suffix": ""}, {"first": "Y", "middle": [], "last": "Chen", "suffix": ""}, {"first": "Z", "middle": [], "last": "Tang", "suffix": ""}, {"first": "W", "middle": [], "last": "Huang", "suffix": ""}, {"first": "J", "middle": [], "last": "Wu", "suffix": ""}, {"first": "D", "middle": [], "last": "Zeng", "suffix": ""}, {"first": "L", "middle": [], "last": "Luo", "suffix": ""}, {"first": "B", "middle": [], "last": "Solomon", "suffix": ""}], "year": 2020, "venue": "J Clin Oncol", "volume": "", "issn": "", "pages": "", "other_ids": {}}, "BIBREF89": {"ref_id": "b89", "title": "Discovery and Development of Potent LFA-1/ICAM-1 Antagonist SAR 1118 as an Ophthalmic Solution for Treating Dry Eye", "authors": [{"first": "M", "middle": [], "last": "Zhong", "suffix": ""}, {"first": "T", "middle": ["R"], "last": "Gadek", "suffix": ""}, {"first": "M", "middle": [], "last": "Bui", "suffix": ""}, {"first": "W", "middle": [], "last": "Shen", "suffix": ""}, {"first": "J", "middle": [], "last": "Burnier", "suffix": ""}, {"first": "K", "middle": ["J"], "last": "Barr", "suffix": ""}, {"first": "E", "middle": ["J"], "last": "Hanan", "suffix": ""}, {"first": "J", "middle": ["D"], "last": "Oslob", "suffix": ""}, {"first": "C", "middle": ["H"], "last": "Yu", "suffix": ""}, {"first": "J", "middle": [], "last": "Zhu", "suffix": ""}, {"first": "M", "middle": ["R"], "last": "Arkin", "suffix": ""}, {"first": "M", "middle": ["J"], "last": "Evanchik", "suffix": ""}, {"first": "W", "middle": ["M"], "last": "Flanagan", "suffix": ""}, {"first": "U", "middle": [], "last": "Hoch", "suffix": ""}, {"first": "J", "middle": [], "last": "Hyde", "suffix": ""}, {"first": "S", "middle": [], "last": "Prabhu", "suffix": ""}, {"first": "J", "middle": ["A"], "last": "Silverman", "suffix": ""}, {"first": "J", "middle": [], "last": "Wright", "suffix": ""}], "year": 2012, "venue": "ACS Med Chem Lett", "volume": "3", "issn": "", "pages": "203--209", "other_ids": {}}, "BIBREF90": {"ref_id": "b90", "title": "Lifitegrast: A novel drug for treatment of dry eye disease", "authors": [{"first": "A", "middle": [], "last": "Abidi", "suffix": ""}, {"first": "P", "middle": [], "last": "Shukla", "suffix": ""}, {"first": "A", "middle": [], "last": "Ahmad", "suffix": ""}], "year": 2016, "venue": "J Pharmacol Pharmacother", "volume": "7", "issn": "", "pages": "194--198", "other_ids": {}}, "BIBREF91": {"ref_id": "b91", "title": "Lifitegrast: First LFA-1/ICAM-1 antagonist for treatment of dry eye disease", "authors": [{"first": "D", "middle": ["M"], "last": "Paton", "suffix": ""}], "year": 2016, "venue": "Drugs Today (Barc)", "volume": "52", "issn": "", "pages": "485--493", "other_ids": {}}}, "ref_entries": {"FIGREF0": {"text": "3targeting the enoyl-[acyl-carrier-protein] reductase (nadh) activity of the mycobacterial type II fatty acid synthase (FAS-II) system[19,20]. Eight of the predicted compounds4 were investigational drugs, namely: DB06638 (quarfloxin, CX-3543), DB12799 (laniquidar), DB06555 (siramesine), DB05075 (TG-100801), DB13050 (tirilazad), DB14895 5 (vibegron), DB11852 (tegobuvir), and DB12341 (LY-2456302/Aticaprant). Quarfloxin is a phenoxazine that binds and stabilizes DNA G-quadruplex (G4) sequences and 6 operates as a direct inhibitor of ribosomal RNA biogenesis [21-25]. Laniquidar is a benzazepine belonging to the 3 rd generation of highly specific and potent P-glycoprotein 7 inhibitors [26-28]. Siramesine is a phenylpyrrole that operates as a selective sigma-2 receptor agonist to induce lysosomal leakage, cytoprotective autophagosome 8 accumulation, and ferroptosis [29-33]. TG-100801 is a depsidone that multitargets vascular endothelial growth factor receptor (VEGFR)/Src kinases-induced viral 9 immunopathology [34,35]. Tirilazad is a nonglucocorticoid, 21-aminosteroid (lazaroid) that potently inhibits oxygen free radical-induced, iron-catalyzed, lipid peroxidation 10 in stroke and chronic obstructive pulmonary disease (COPD) [36,37]. Vibegron (RVT-901/MK-4618/KRP-114V) is a beta-3 adrenergic receptor beta 3 (\u03b23AR) agonist 11 employed for the treatment of overactive bladder [38-40]. Tegobuvir is a non-nucleoside phenylpyridazine targeting the hepatitis C Virus RNA-dependent RNA NS5B12 polymerase[41][42][43][44]. LY-2456302/Aticaprant is a diphenylether targeting the \u03ba-opioid receptor (KOR) used as a candidate to treat major depressive disorder[45,46]. Two of 13 the predicted compounds were FDA-approved drugs, namely: DB00872 (conivaptan) and DB09143 (sonidegib). Conivaptan is a benzalnilide targeting the vasopressin 14 receptors V1a and V2 that has been approved for hyponatremia (low blood sodium levels) caused by syndrome of inappropriate antidiuretic hormone (SIADH)[47,48].", "latex": null, "type": "figure"}, "FIGREF1": {"text": "12, x; doi: www.mdpi.com/journal/viruses", "latex": null, "type": "figure"}, "FIGREF2": {"text": "the predicted compounds were experimental drugs, namely: DB04016 [2-[3-({methyl[1-(2-naphthoyl)piperidin-4-yl]amino}carbonyl)-2-naphthyl]-1-(1-naphthyl)Amino]Phenoxy}Phthalic Acid], DB06896 [1-(4-fluorophenyl)-N-[3-fluoro-4-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)phenyl]-2-oxo-1,2-dihydropyridine-3carboxamide], DB02449 [3-(1h-indol-3-yl)-2-[4-(4-phenyl-piperidin-1-yl)-benzenesulfonylamino]-propionic acid].DB04016 is a stilbene targeting the serine-type endopeptidase activity of cathepsin G. AP-22408 is a phenylalanine derivative targeting the Sh2 domain of the tyrosine-protein kinase Lck [52,53]. DB08233 is a hypoxanthine targeting cyclin-A2 and cyclin-dependent kinase 2. DB03067 is a benzanilide targeting pyridoxal phosphate binding of the glycogen phosphorylase. DB06896 is an aromatic anilide targeting the c-MET/hepatocyte growth factor receptor. DB02449 is a phenylpiperidine targeting stromelysin-1 (MMP3). Six of the predicted compounds were investigational drugs, namely: DB13109 (PKI-179), DB05678 (SLx-4090), DB15308 (ridinilazole), DB12154 (itacitinib), DB13042 (fenoverine), and DB15057 (acelarin/NUC-1031). PKI-179 is a N-phenylurea that dually targets the phosphatidylinositol-3-kinase (PI3K)/mammalian target of rapamycin (mTOR) pathway[54,55]. SLx-4090 is a microsomal triglyceride transfer protein (MTTP) inhibitor potentially for the treatment of type 2 diabetes[56]", "latex": null, "type": "figure"}, "FIGREF3": {"text": "BGB324, bemcentinib) is an aralkylamine that selectively and potentially inhibits AXL, a receptor tyrosine kinase implicated in epithelial-to-mesenchymal transition (EMT), inflammation, fibrosis, and is a key suppressor of innate immune response [68-72]. RAF-265 is a potent RAF/VEGFR2 inhibitor[73]. Antrafenine is a piperazine derivative drug that acts as an analgesic and anti-inflammatory drug with similar efficacy to naproxen via inhibition of cyclooxygenase activity[74].", "latex": null, "type": "figure"}, "TABREF0": {"text": "DB03231 is an N-benzylbenzamide targeting the dehydroneopterin aldolase activity in Staphylococcus aureus. DB06925 is a benzalnilide targeting the Lck protein, an Src family tyrosine kinase playing a critical role in T cell maturation and activation.", "latex": null, "type": "table"}, "TABREF2": {"text": "Drug candidates targeting the nsp16/nsp10 interface of the nsp16/nsp10 protein complex. pyridine-2-carboxamide], and DB04289 (Genz-10850). DB06938 is a diarylether targeting vascular endothelial growth factor receptor 2 (VEGFR2). Genz-10850 is a fluorene", "latex": null, "type": "table"}, "TABREF3": {"text": "Drug candidates targeting the RNA-binding groove of the nsp16/nsp10 protein complex.", "latex": null, "type": "table"}, "TABREF4": {"text": "Drug candidates targeting the SAM-binding site and nsp16/nsp10 interface of the nsp16/nsp10 protein complex.", "latex": null, "type": "table"}, "TABREF5": {"text": "Drug candidates targeting the SAM-binding site and RNA-binding groove of the nsp16/nsp10 protein complex.", "latex": null, "type": "table"}, "TABREF6": {"text": "Drug candidates targeting the nsp16/nsp10 interface and RNA-binding groove of the nsp16/nsp10 protein complex.", "latex": null, "type": "table"}, "TABREF7": {"text": "Drug candidates targeting the SAM-binding site, nsp16/nsp10 interface, and RNA-binding groove of the nsp16/nsp10 protein complex.", "latex": null, "type": "table"}, "TABREF8": {"text": "Filtering of nsp16/nsp10-targeting candidate drugs based on MD simulations for drug-protein complexes.Table S10. Selection of nsp16/nsp10-targeting candidate drugs based on MD simulations for drug-protein complexes.", "latex": null, "type": "table"}}, "back_matter": []}